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Abstract
This pilot study aimed to examine the effect of an acute bout of exercise on smoking
behavior (topography) subsequent to a temporary period of smoking abstinence. Fortythree adult smokers (female = 34, Mage = 43.14), who had been smoking for an average of
23.90 years, were randomized to either an exercise (n = 21) or passive sitting group.
Thirty-one smokers completed the study. The primary outcome variables included: puff
count, puff volume, puff duration, inter-puff interval (IPI), and total cigarette duration.
The effect of exercise on smoking topography was non-significant. Overall, the
effectiveness of exercise as an additional harm reduction strategy was not supported.

Keywords: smoking, smoking topography, harm reduction, desire to smoke
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Chapter One: Literature Review
Introduction

Tobacco use is the foremost preventable cause of death and disease worldwide
(WHO, 2011). In Canada, an estimated 4.7 million (16.7%) people aged 15 years or
older are current smokers. Smoking prevalence is higher among males (19.7%) than
females (13.8%), is highest among young adults (age 20-24), at 22.1% (CTUMS, 2010),
and is related to socio-demographic factors, such as: socio-economic status, ethnicity, and
education level (CTUMS, 2010; CDC, 2007). Cigarette smoking is a risk factor for longterm health consequences. The long-term health consequences of cigarette smoking
include: cardiovascular disease (e.g., coronary heart disease, atherosclerosis), cancer
(e.g., lung, kidney, esophageal), pulmonary disease (e.g., chronic obstructive pulmonary
disease, pneumonia), and other health complications (e.g., delayed wound healing,
osteoporosis, reproductive disorders). The evidence is sufficient to conclude that
smoking damages nearly every organ of the body (USDHHS, 2004). Greater than 37 000
deaths each year in Canada are attributed to tobacco use (Peto, Lopez, Boreham, Thun, &
Heath, 1992), and approximately one half of current smokers will become ill or die from
continued use (Baliunas, Patra, Rehm, Popova, Kaiserman, & Taylor, 2007). The burden
of smoking does not fall solely on the individual; smoking is associated with significant
economic and health care costs. The estimated social cost of tobacco use is $17 billion
per year (Rehm et al., 2006), and tobacco-related illness costs Canadians approximately
$4.4 billion in direct health care costs each year (Rehm et al., 2006). Currently, the
prevalence of smoking in Canada is a record low (16.7%); but, there is a trend towards
smaller declines each year (CTUMS, 2010). Effective and economical smoking cessation
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interventions are needed.
In this chapter, the literature will be reviewed on why it is difficult to quit
smoking. Evidence for the acute effect of exercise on tobacco withdrawal symptoms and
mood will also be reviewed and critiqued. Next, the literature on how a person smokes
(i.e., smoking topography) will be summarized. Last, the literature on the utility of
exercise as a harm reduction strategy, and research on the effect of an acute bout of
exercise on smoking topography will be reviewed.
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Why is it difficult to quit smoking?
There is short- and long-term health benefits associated with a successful quit
smoking attempt. The short-term benefits of quitting smoking include: reduced heart
rate, removal of carbon monoxide (CO), improved sense of taste and smell, and improved
lung function. The long-term benefits of quitting smoking include a decreased risk of
lung cancer, cardiopulmonary disease, and stroke, and prolonged life expectancy. The
majority (60.2%) of smokers in Canada indicate an interest in quitting smoking in the
next six months, and an estimated 46.6% of smokers have made at least one quit attempt
in the past year (CTUMS,2010). Yet, among smokers who attempted to quit in the past
year, only 1 in 10 were abstinent at time of survey (CTUMS, 2010). In addition, the
success rate (6 to 12 months prolonged abstinence) of unaided stop smoking attempts is
3-5% (Hughes, Keely, & Naud, 2004). The low success rate of stop smoking attempts is
strong evidence that quitting is difficult.
Nicotine is the cigarette constituent responsible for addiction (USDHHS, 1988).
When tobacco smoke is inhaled, nicotine is distilled from a cigarette and crosses the
blood-brain barrier. Nicotine accumulates in the brain rapidly. A high level of nicotine
can reach the brain in 10-20 seconds (Benowitz, Hukkanen, & Jacob III, 2009). Nicotine
binds to nicotinic cholingeric receptors (nAChRs) and causes the release of
neurotransmitters, including: dopamine, glutamate, gamma-amino-butyric acid (GABA)
(Benowitz, 2009). The release of neurotransmitters is important to the development of
nicotine dependence. For example, dopamine is involved in drug induced reward (Dani
& De Biasi, 2001) and pleasure (Nestler, 2005). The speed of nicotine delivery to the
brain via smoking contributes to addiction.
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Defining addiction and dependence. Addiction is defined as “a primary,
chronic, neurobiologic disease, with genetic, psychosocial, and environmental factors...It
is characterized by behaviors that include one or more of the following: impaired control
over drug use, compulsive use, continued use despite harm, and craving” (Schnoll,
Johnson, Lerman, 2007).
The Surgeon General’s report (USDHHS, 1988) outlined the criteria for drug
dependence, including nicotine. According to this report, drug dependence is defined by
primary and additional criteria. The criteria are presented in Table 1.

Table 1
Primary and additional criteria for drug (nicotine) dependence (USDHHS, 1988)
Primary Criteria

Additional Criteria

Highly controlled or compulsive use

Addictive behavior often involves:

Psychoactive effects

Stereotypic patterns of use

Drug-reinforced behavior

Use despite harmful effects
Relapse following abstinence
Recurrent drug cravings
Dependence-producing drugs often produce:
Tolerance
Physical dependence
Pleasant (euphoriant) effects
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According to the Diagnostic and Statistical Manual of Mental Disorders (DSMIV) (American Psychiatric Association, 2000), the term dependence is suggestive of a
mental disorder. The symptoms of substance dependence include: (a) drug tolerance; (b)
continued use despite harm; (c) loss of control; (d) unsuccessful attempts to decrease use;
(e) salience; (f) reduced involvement in life; and (g) substance withdrawal (American
Psychiatric Association, 2000). Substance dependence is diagnosed if at least three of the
aforementioned symptoms have occurred in the preceding 12 months. The term
dependence is used throughout this paper.
A hallmark of nicotine dependence is tobacco withdrawal symptoms, including
cigarette cravings. A cigarette craving is the most common symptom of withdrawal. A
craving (i.e., urge to smoke) is defined as a subjective emotional state; it is responsible
for continued tobacco use in dependent smokers (Kozlowski & Wilkinson, 1987).
Tobacco withdrawal symptoms emerge when a nicotine dependent person stops smoking.
Withdrawal symptoms include: irritability, depressed mood, restlessness, anxiety,
difficulty concentrating, increased hunger and eating, and insomnia (Hughes &
Hatsukami, 1986). Overall, tobacco withdrawal is characterized by behavioral, cognitive,
and physiological symptoms. People continue to smoke in order to avoid withdrawal
symptoms (i.e., negative reinforcement) and to enhance positive affect (i.e., positive
reinforcement) (USDHHS, 2010).
The environment and social situations reinforce cigarette smoking. A cigarette
smoker may associate an environment, mood, and/or social situation with a subjective
feeling of reward. For instance, due to repeated exposure, a cigarette smoker may
develop a habit of smoking after a meal, with a cup of coffee, or with friends who smoke
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(Benowitz, 2009). The association between cigarette smoking and positive affect (e.g.,
stimulation, arousal, and stress reduction) is also strengthened due to repeated exposure.
Last, a smoker may integrate the behavior into their social life. Family, friends, and ones
identity are often linked to smoking.
A dependence on cigarette smoking is a result of the product (e.g., addictive
constituents), the host (person) response (e.g., physiological, psychological), and the
environment or social setting (USDHHS, 2010). It is the complex relationship of the
biological, psychological, and social pull of cigarettes that makes stopping smoking
difficult. Treating nicotine dependence is an area of interest for researchers and health
practitioners. Several pharmacological and counselling therapies have been and continue
to be under investigation (e.g., nicotine replacement therapy (NRT) (Stead, Perera,
Bullen, Mant, & Lancaster, 2008), varenicline (Gonzales et al., 2006), bupropion (Fiore
et al., 2008; Jorenby et al., 2006), motivational interviewing (Butler, Rollnick, Cohen,
Bachmann, Russell, Stott, 1999).
Exercise is a potential smoking cessation adjunct (Taylor, Ussher, & Faulkner,
2007; Ussher, Taylor, & Faulkner, 2008). Marcus and colleagues (1999) demonstrated
that vigorous intensity exercise combined with cognitive behavioral support facilitates
smoking cessation. In addition, Williams and colleagues (2010) demonstrated that
moderate intensity exercise may enhance the efficacy of a combined nicotine replacement
therapy (NRT) and cessation counseling program, but only with adequate adherence. In
contrast, past research demonstrated that quit rates following a 12-week combined
bupropion and exercise program were not significantly higher when compared to a
placebo (Abrantes et al., 2009). Overall, the research does not consistently show that
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exercise aided interventions improve long-term cessation rates (Ussher et al., 2008).
The current study is concerned with the impact of an acute bout of exercise on
smoking outcomes. Hence, the remainder of this chapter will focus on current literature
in this paradigm.

Acute Effect of Exercise on Smoking Outcomes
Taylor and colleagues (2007) conducted a systematic review on the acute effects
of exercise on tobacco withdrawal, cravings, affect, and smoking behavior. To analyze
the effect of exercise on smoking outcomes (e.g., cravings, withdrawal symptoms, and
affect), a single bout of exercise is typically compared to a passive condition. In addition,
smoking outcomes are usually assessed following a temporary period of smoking
abstinence.
Withdrawal symptoms. Taylor and colleagues (2007) showed that a single
session of exercise significantly decreased some tobacco withdrawal symptoms; namely,
psychological stress, anxiety, tension, poor concentration, irritability, and restlessness
(Taylor et al., 2007). A session of exercise, 5 to 10 minutes in duration, reduced tobacco
withdrawal symptoms among smokers who were temporarily abstinent (Daniel, Cropley,
Ussher, & West, 2004; Ussher, Nunziata, Cropley, & West, 2001). The magnitude of
reduction in withdrawal symptoms was similar to the reduction in cravings. Tobacco
withdrawal symptoms were significantly reduced both during and after exercise.
Cigarette cravings. A systematic review by Taylor and colleagues (2007)
proved that a single session of exercise significantly decreased cigarette cravings.
‘Strength of desire to smoke’ was significantly reduced during and after exercise. In the
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review, a moderate to large effect size (ES) was shown (.50 – 4.6; Taylor et al., 2007).
This effect was present for different intensities, durations, and types of exercise. For
example, Ussher and colleagues (Ussher, West, Doshi, & Sampuran, 2006) showed that
isometric exercise for five minutes reduced the urge to smoke by .7 on a seven point scale
(ES = .29). In addition, Taylor and colleagues (2005) showed that a self-paced brisk
walk for one mile reduced the desire to smoke by 4.6 on a seven point scale (ES = 3.7).
A significant reduction in cigarette cravings has been shown for walking (e.g., Taylor,
Katomeri, & Ussher, 2006; Janes VanRensburg & Taylor, 2008); stationary cycling (e.g.,
Ussher et al., 2001; Daniel, Cropley, & Fife-Schaw, 2006), isometric exercise (e.g.,
Ussher et al., 2006), and Hatha yoga (Elibero, Janes Van Rensburg, & Drobes, 2011).
Taylor and colleagues (2007) reported that craving reduction was most significant
immediately subsequent to exercise; but, a significant post-treatment effect has also been
found for up to 30 minutes post-treatment (Ussher,Cropley, Playle, Mohidin, & West,
2009; Scerbo, Faulkner, Taylor, & Thomas, 2010). The magnitude of reduction in
cigarette cravings following a single session of exercise was comparable to the effect of
oral nicotine replacement therapy (NRT) (West & Shiffman, 2001). Overall, the
evidence clearly indicated that a single session of exercise reduced cigarette cravings.
General mood and affect. Researchers have shown that an acute bout of
exercise enhanced mood and affect (e.g., Taylor et al., 2006; Thayer, Peters, Takahaski,
& Birkhead-Flight, 1993; Elibero et al., 2011; Everson, Daley, & Ussher, 2006). An
increase in activation and energy (Taylor et al., 2006; Thayer et al., 1993), and a
reduction in tension have also been found in response to a solitary bout of exercise
(Taylor et al., 2006). Last, Everson and colleagues (2008) demonstrated that a 10 minute
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bout of moderate intensity cycling increased positive well-being and decreased
psychological distress. Changes in mood and affect may mediate a reduction in cravings
(Taylor et al., 2006; Roberts, Maddison, Simpson, Bullen, & Prapavessis, in press).
Possible mechanisms. A solitary session of exercise may be a coping strategy
for temporary relief of tobacco withdrawal symptoms (Taylor et al., 2007). Previous
research has examined factors that may affect this relationship. The mechanisms that
have been examined include: distraction (Daniel et al., 2006; Ussher et al., 2006), mood
and affect (Everson et al., 2008; Elibero et al., 2011), shifts in attention (Janse Van
Rensburg, Taylor, & Hodgson, 2009), exercise expectancy (Daniel et al., 2006; Harper,
Fitzgeorge, & Prapavessis, 2011), credibility (Harper et al., 2011), and neurobiological
changes such as increases in dopamine (Wilson & Marsden, 1995) and catecholamines
(Richter & Sutton, 1994; Ward, Garvey, Bliss, Sparrow, Young, & Landsberg, 1991).
Overall, previous research has explored several mechanisms that may affect the exercise
and craving relationship, however, the evidence is not clear.
Limitations of the acute paradigm. The acute exercise and smoking paradigm
has two inherent pitfalls. First, research is often carried out in a laboratory. Smoking
cues can be controlled in this setting; but, it does not resemble a ‘real world’ experience.
Second, acute studies often consist of a temporary period of abstinence. Tobacco
withdrawal symptoms may not align with symptoms experienced during a quit attempt.
Overall, the ecological validity of studies in the acute paradigm is in question.

Overview of Smoking Behavior (topography)
Exposure to the elements of cigarette smoke (e.g., tar, carbon monoxide, and
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nicotine) is associated with health consequences (Frederiksen, Martin, & Webster, 1979).
The number of cigarettes per day (i.e., rate of cigarette consumption) is the common
gauge of exposure; but, the way a person smokes a cigarette (i.e., smoking topography) is
also significant (Frederiksen et al., 1979). A number of variables form smoking
topography, including: puff count, puff volume, puff velocity, inter-puff interval, puff
duration, and time to first puff.
The process of cigarette smoking is complex (Benowitz et al., 2009); the way a
person smokes a cigarette is important for a number of reasons. First, exposure to carbon
monoxide (Zacny, Stizer, Brown, Yingling, & Griffiths, 1987) and carcinogenic elements
(Djordjevic, Stellman, & Zang, 2000) is influenced by puff indices, such as puff volume.
The analysis of smoking topographical indices is an estimate of exposure to the harmful
elements of a cigarette. Second, the analysis of smoking topographical indices has
clinical implications (Perkins, Karelitz, Giedgowd, & Conklin, 2011). Previous research
has demonstrated that some topographical variables (e.g., maximum puff velocity, puff
volume, inter-puff interval) predicted abstinence after a stop smoking attempt using
nicotine replacement therapy (NRT) (Strasser, Pickworth, Patterson, & Lerman, 2004).
Third, smoking topography is a gauge of smoking reinforcement and reward. The
assessment of topographical indices may be of use in helping researchers understand the
factors that sustain cigarette smoking. Overall, the measurement of topography is of use
in stop smoking interventions and in the gauge of harm from smoking.
The measurement of smoking behavior. Topographical variables can be
measured by self-report, observation, or via an instrument.
A smoker is best positioned to monitor their smoking behavior across different
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situations (Frederiksen et al., 1979). A self-report questionnaire is simple and efficient.
But, self-report is a retrospective account of behavior, therefore it may not be accurate. A
variation of self-report is self-monitoring. Self-monitoring is a practical and flexible
method. Unfortunately, it is a burden to the subject. Overall, self-report assessment of
smoking behavior is practical, but the accuracy is questioned.
Direct observation is the crux of behavior research. Researchers have examined
topographical variables by observation. Observation by trained observers and
videotaping of smoking patterns are the common forms of observation (Frederiksen,
Miller, & Peterson, 1977; Frederiksen et al., 1979). Some topographical variables can be
measured accurately by observation (e.g., puff count, total cigarette duration). But, it is
difficult to measure intricate variables, such as inter-puff interval, puff volume, and puff
duration. Smoking behavior is often observed in a laboratory setting. A smoker may
take more and longer puffs, and smoke more quickly in a laboratory than in a natural
setting (Ossip-Klein, Martin, Lomax, Prue, & Davis, 1983). Observation of topography
is difficult; it is not an accurate reflection of normal smoking behavior.
A variety of instruments have been used to objectively measure topographical
variables. Past research has used pneumotachographs (e.g., Zacny et al., 1987), pressure
transducers (e.g., Ossip-Klein et al., 1983), portable recorders (e.g., Hatsukami, Morgan,
Pickens, & Champagne, 1990), flowmeters (e.g., Ahijevych, Gillespie, Demirci, &
Jagadeesh, 1996), and puff analyzers (e.g., Sutton, Russell, Iyer, Feyerabend, & Saloojee,
1982). Technological advances have resulted in the development of a sophisticated
device called the CReSS Pocket (Clinical Research Support System; (CReSS; Plowshare
Technologies®, Borgwalt, KC. Inc., Richmond, Virginia, USA). Previous research has

12

used the CReSS Pocket to quantify topographical variables (e.g., Lee, Malson, Waters,
Moolchan, & Pickworth, 2003; Faulkner, Arbour-Nicitopoulous, & Hsin, 2010; Blank,
Disharoon, & Eissenberg, 2009).
Variability in smoking topography. Cigarette smoking topography is
influenced by several variables, including sex, and nicotine dependence. First, previous
research provided evidence that mean puff volume, and mean puff duration were affected
by sex (Eissenberg, Adams, Riggins III, & Likness, 1999). Puff volume and puff
duration were greater in males than females (Eissenberg et al., 1999). Second, total
volume and maximum puff volume were greater in smokers with a high level of nicotine
dependence (Perkins et al., 2011). Third, previous research provided evidence that body
mass index (BMI) and the length of deprivation influenced subjective reinforcement
(Blendy et al., 2005; Zacny & Stitzer, 1985). Subjective reinforcement may be related to
objective topographical variables. Overall, the consideration of variables such as, sex,
nicotine dependence, BMI, and length of abstinence is warranted in topography research.
Exercise as a potential harm reduction strategy. There are ‘hardened’ smokers
who are unable or unwilling to attain cessation. In addition to tobacco withdrawal
symptoms and cravings, the social and psychological dependence on nicotine is difficult
to overcome. A harm reduction strategy may be best suited for ‘hardened’ smokers.
Harm reduction can refer to a strategy or intervention that involves continuation of a high
risk behavior (e.g. smoking); but, the primary objective is to lower the risk of morbidity
and mortality (Stratton, Shetty, Wallace, & Bondurant, 2001; Hatsukami, Henningfield,
& Kotlyar, 2004). At present, nicotine replacement therapy (NRT) is the only strategy to
satisfy all eight criterion of harm reduction (de Ruiter & Faulkner, 2006). However,
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regular physical activity may be an additional harm reduction approach (de Ruiter &
Faulkner, 2006; Hatsukami et al., 2004).
A harm reduction strategy should satisfy the following eight criterion: (1) reduce
the occurrence of death and disease; (2) not present additional health or safety risks; (3)
should not further contribute to an individual’s level of nicotine dependence; (4) not
increase the prevalence of tobacco dependence; (5) no reduce the likelihood of eventual
cessation; (6) allow a smoker to become tobacco and nicotine free; (7) not lure
adolescents or lead to misuse by adolescents; and (8) smoking cessation messages should
be incorporated into promotion of the harm reduction approach (Hatsukami et al., 2004).
de Ruiter and Faulkner (2006) postulate that regular physical activity may satisfy each
principle.
A solitary session of exercise can provide cigarette craving and tobacco
withdrawal relief (Taylor et al., 2007). A solitary session of exercise may also delay time
to ad libitum smoking (Reeser, 1983; Katomeri & Taylor, 2006; Taylor & Katomeri,
2007; Thayer et al., 1993). In addition, there is emerging evidence for a positive change
in smoking topography subsequent to exercise (Faulkner et al., 2010). Taken as a whole,
an acute bout of exercise has the potential to contribute to smoking harm reduction. The
effect of an acute bout of exercise on time to ad libitum smoking and objective
topographical variables (Reeser, 1983; Mikhail, 1983; Faulkner et al., 2010) will be
further discussed in the remainder of this chapter.

Exercise and Smoking Behavior (topography)
Ad libitum smoking behavior. Four studies (Reeser, 1983; Thayer et al., 1993;
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Katomeri & Taylor, 2006; Taylor & Katomeri, 2007) have investigated the effect of a
single session of exercise on time to ad libitum smoking. The treatment effects range
from a net time of 8 (Katomeri & Taylor, 2006) to 57 (Taylor & Katomeri, 2007)
minutes. Post-treatment desire to smoke predicted the time to first cigarette. A lower
desire to smoke (r = -0.26, p<.05) was associated with an increased time to first cigarette
(Taylor & Katomeri, 2007). Overall, previous research has found that a 5 to 20 minute
bout of exercise increased the time to a next cigarette (Reeser, 1983; Thayer et al., 1993;
Katomeri & Taylor, 2006; Taylor & Katomeri, 2007).
There are two caveats of the aforementioned evidence that warrant discussion.
First, the researchers used dissimilar experimental designs. For example, different
lengths of smoking abstinence, and different types and intensities of exercise were
reported. Also, the level of nicotine dependence was not congruent across studies.
Second, time to first cigarette was based on self-report accounts. Self report accounts
may have biased and/or contaminated the findings.
The evidence that a solitary session of exercise can delay the time to a next
cigarette is encouraging. As the length of time between cigarettes is increased, the
number of cigarettes smoked per day (i.e., rate of consumption) is decreased. A reduced
rate of consumption is a type of harm reduction (de Ruiter & Faulkner, 2010). But, a
delay in ad libitum smoking does not account for the complex nature of cigarette
smoking. Thus, an in-depth evaluation of objective smoking topography is needed.
Acute effects of exercise on smoking topography. Two unpublished Master’s
Theses (Reeser, 1983; Mikhail, 1983) each investigated the effect of exercise on time to
first cigarette, puff count, and duration of first cigarette following a 30 minute period of
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smoking abstinence. Direct observation was used to measure the topographical variables.
Reeser (1983) equated data from two laboratory sessions. A randomized
between subject design was used. There were three conditions: (a) cycling (60%
maximum heart rate); (b) stretch and isometrics; and (c) passive. Each condition was
succeeded by a 30 minute observation period; 28% of subjects in either the stretching and
isometrics condition or the cycling condition did not smoke during the 30 minute
observation period, compared to 15% in the passive condition. The stretching and
isometric condition had fewer puffs with the first cigarette than the passive condition (ES
= .69). Also, on average, the stretching and isometric condition smoked 31 minutes postcondition; whereas, the passive condition smoked a mean of 7 minutes post-condition.
Interestingly, the cycling condition smoked a mean of 14 minutes post-condition.
Mikhail (1983) used a within subject experimental design. There were three
conditions: (a) cycling (66-69% maximum heart rate); (b) cycling (82-85% maximum
heart rate); and (c) passive (reading). Each condition was succeeded by a 60 minute
observation period. The time length of the first cigarette was greater for the passive
condition compared to either cycling condition. In a 23 hour post-laboratory period,
participants also recorded the number of cigarettes smoked. Overall, the difference
between the two cycling conditions was non-significant, and no other effects (e.g.,
number of puffs per cigarette, number of cigarettes in follow-up period) were reported
(Mikhail, 1983).
The overall duration (Mikhail, 1983), and puff count (Reeser, 1983) of a cigarette
were reduced subsequent to a solitary session of exercise compared to a passive
condition. There were limitations of the aforementioned research. First, smoking
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behavior was measured in a laboratory setting. Although exposure to smoking stimuli
can be controlled within a laboratory, the setting is not ecologically valid (Frederiksen et
al., 1979). Second, both Reeser (1983) and Mikhail (1983) only measured puff count and
total duration. Total duration and puff count, along with time to first cigarette provide an
incomplete depiction of smoking behavior. The investigation of more complex and
objective topographical indices subsequent to exercise was needed.
Faulkner and colleagues (2010) provided the first evidence for the effect of an
acute bout of exercise on objective smoking topography. Faulkner and colleagues (2010)
used a within subject design, with two conditions: (1) passive sitting (control); and (2)
brisk walking (experimental). The CReSS Pocket was used to measure puff volume, puff
duration, puff count, inter-puff interval, and the time to first puff in a 20-minute postcondition period. In addition, desire for a cigarette was assessed pre-, during, and postcondition. Faulkner and colleagues (2010) reported that participants in the brisk walking
condition smoked a lower volume per puff compared to the passive condition. Puff
duration was also reduced for the brisk walking condition. The effects were present after
controlling for the length of smoking abstinence. Also, the trends were in favor of the
walking condition for the remaining topographical variables. Last, Faulkner and
colleagues (2010) reported a correlation between craving reduction and time to first puff,
such that the greater the reduction in cravings, the greater the time to first puff.
There are several caveats of the aforementioned study by Faulkner and colleagues
(2010) that warrant discussion. First, a within subject design was used to investigate the
effect of brisk walking on smoking topography. A within subject design has advantages
(Maxwell & Delany, 2004), but it cannot show a cause and effect relationship. The
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results may be strengthened with the use of a randomized between subject design.
Second, the exercise condition was a ten minute session of light intensity walking. The
time and intensity of exercise were insufficient to show an effect in an active sample. A
moderate intensity session that is acclimated to each subjects resting heart rate may be
more effective. Third, the average length of smoking abstinence reported by Faulkner
and colleagues (2010) was 8.4 hours. Past research reported that a 15 hour period of
smoking abstinence can give rise to heightened withdrawal symptoms (Ussher et al.,
2001; Daniel et al., 2004). A longer period of smoking deprivation may be needed to
show a significant change in smoking topography. Overall, future exercise and smoking
topography research should consider the caveats of this study.

Objective and Hypothesis
Primary objective. The purpose of the current study was to investigate the effect
of an acute bout of moderate intensity exercise on smoking topography variables (puff
count, puff duration, puff volume, inter-puff interval, and total duration) following a
temporary period of smoking abstinence, compared to a passive condition.
Primary hypothesis. Participants in the moderate intensity exercise condition
will demonstrate positive changes in smoking topography (i.e., reduced puff count, puff
duration, puff volume, total duration, and increased inter-puff interval) compared to a
passive condition.
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Chapter Two: The Current Study

Method
The subsequent methods are reported in accordance with CONSORT principles
(www.consort-statement.org). The conduct of this study adhered to guidelines of the
Declaration of Helsinki (World Medical Association, 2008) and the World Health
Organization (WHO) 2002 Good Clinical Research Practice. This study was registered
with Clinical Trials, a service of the United States National Institute of Health
(NCT01417975). All participants read the Letter of Information (Appendix A), had
his/her questions answered, and signed a Consent Form (Appendix A) prior to
participation in this study.

Design
The research used a stratified (age, sex, physical activity level, nicotine
dependence) two group randomized controlled trial design. Randomization was
accomplished by a computer-generated numbers table for age (18-30 years, 31-50 years,
51-64 years), sex (male, female), physical activity level (active, inactive), and nicotine
dependence (low, high). Participants were blinded to group allocation and were unaware
of the existence of a second condition.

Participants
Inclusion criteria included: (1) aged 18 to 64 years; (2) smoke 10 or more
cigarettes per day for at least two years; and (3) completion of the Physical Activity
Readiness Questionnaire (PAR-Q; Canadian Society for Exercise Physiology (CSEP),
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2002). Exclusion criteria included: (1) contraindication to physical activity (e.g.,
disability, unstable angina); (2) a positive answer to one or more questions on the PARQ; (3) pregnant or intending on becoming pregnant before completion of the study; (4)
engaged in a quit attempt in past 6 months; and (5) suffering from a illness (e.g., cold)
that would compromise normal smoking behavior. Forty-three participants (Mage = 43.14
years, SD =13.01) who satisfied all criteria were randomized into one of two conditions:
moderate intensity exercise or passive sitting. Participants included 34 females and nine
males.

Demographic characteristics
Demographic information, including: age, gender, smoking status (e.g., number of
cigarettes per day, current other substance use, date and time of last cigarette, and brand
and type of cigarette smoked most often), and smoking history (e.g., number of years
smoking regularly, age of first cigarette, and past other substance use) was collected.
Height (cm) and weight (kg) were recorded and Body Mass Index (BMI) was calculated.

Primary Outcome Measure
Smoking behavior (topography). The CReSS Pocket (Clinical Research
Support System; Plowshare Technologies®, Borgwalt, KC. Inc., Richmond, Virginia,
U.S.A) measured smoking topography. The CReSS Pocket is a portable, batteryoperated machine. The machine is a hand-held unit that consists of a specialized
mouthpiece. The mouthpiece produces a pressure drop that is converted to a flow rate.
All variables are derived from the measurement of flow and time (Hammond, Fong, &
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Cummings, 2005). The topography markers acquired from the CReSS Pocket include:
(1) puff count (number of puffs); (2) puff volume (ml); (3) puff duration (seconds); (4)
inter-puff interval (IPI; seconds); and (5) time to first puff (seconds). In addition to the
values acquired from the CReSS Pocket, total duration (minutes) was calculated. Total
duration (minutes) was derived from the start and end time. Time to first puff was not
included in the current study. Data were downloaded from the device immediately upon
collection. A serial port computer interface was used to download the data. The CReSS
Pocket has excellent test-retest reliability for puff duration (α ≥0.75) (Lee et al., 2003)
and fair- to - good reliability for puff volume (0.4 > α < 0.75) (Lee et al., 2003).
Topographical data were inspected for errors of measurement. Erroneous puffs
can result from device misuse and/or imprecision. The first puff and any puffs with a
volume less than 12 ml were deleted from the data set. The data for all remaining puffs
were averaged to obtain one value for each topography marker. Data for the light-up puff
was not included as it bears no resemblance to subsequent puff (in terms of volume and
duration), and is often not inhaled by the smoker (Zacny & Stitzer, 1985). The criterion
for false puffs has been previously used (Lee et al., 2003).

Other Measures
Desire to smoke. The single-item statement ‘I have a desire to smoke’ (Tiffany
& Drobes, 1991) assessed desire to smoke. The item was scored on a seven-point Likert
scale, from 1 (strongly disagree) to 4 (neither agree nor disagree), and 7 (strongly
agree). Desire to smoke was measured at baseline (Session 1), the start of Session 2, and
one-minute post-condition (Session 2).

21

Physical activity questionnaire. The short-form International Physical Activity
Questionnaire (IPAQ; Craig et al., 2003) gauged current physical activity, including: (1)
walking; (2) moderate-intensity; and (3) vigorous-intensity activities. The IPAQ is a selfreport recall of physical activity in the previous seven days. The questionnaire was
administered at baseline. Physical activity was defined by metabolic equivalent task
(METs) units. A MET-minute was calculated by multiplying the MET unit by the
number of minutes. One measure of activity was computed to yield a score of total
MET-minutes/week. The MET scores used in the calculation of the IPAQ data include:
(1) walking = 3.3 METs; (2) moderate physical activity = 4.0 METs; and (3) vigorous
physical activity = 8.0 METs. The IPAQ also measured the number of sitting hours per
day. Time spent sitting is an indicator of sedentary activity; therefore, it was not included
in the total score of physical activity. Participants were classified as inactive (< 1500
MET-minutes per week) or active (≥1500 MET-minutes per week).
Fagerstrӧm test for nicotine dependence. Behavioral and physiological aspects
of dependence were measured by the Fagerstrӧm Test for Nicotine Dependence (FTND;
Heatherton, Kozlowski, Frecker, & Fagerstrӧm, 1991). The FTND was administered at
baseline (Session 1). The FTND is a six-item, multi-dimensional scale, summarized as a
single score. This study used a median split of FTND scores, with five or higher
indicating high dependence and below five indicating low dependence. The FTND has
good internal consistency (α=.64, p <.001) and adequate test-retest reliability (r = .88)
(Pomerleau, Carton, Lutzke, Flessland, & Pomerleau, 1994). In the current study, the
FTND had adequate internal consistency (α = .65).
Acceptability of the CReSS Pocket. The acceptability questionnaire assessed

22

participants’ experience with the CReSS Pocket. The purpose built questionnaire
consisted of 11-items that assessed the degree to which the CReSS Pocket “altered
smoking behavior” (i.e. puff volume, time between puffs, puff duration, puff count, and
cigarette duration), “reduced smoking enjoyment,” “affected the taste of the cigarette,”
“made smoking more difficult,” and “increased awareness of how much was smoked.”
Acceptability of puff velocity and likeliness to smoke were not included in the
subsequent analysis because they did not represent smoking topography variables. The
scale ranged from 0 (strongly disagree) to 100 (strongly agree). Acceptability of the
CReSS Pocket was assessed following baseline (Session 1) and Session 2 smoking
topography measurement. This questionnaire has not been validated. In the current
study, the questionnaire had very good internal consistency at baseline (α = .942) and
Session 2 (α = .961).

Intervention
Moderate intensity exercise. The experimental condition involved a single bout
of moderate intensity exercise on a Woodway PPS treadmill (Woodway, Waukesha, WI).
The activity bout included a warm-up, 10 minutes of exercise (equivalent to moderate
intensity) and a cool-down. Moderate intensity was defined as 40-68% of heart rate
reserve (HRR) (Karvonen, Kentala, & Mustala, 1957). Heart rate reserve (HRR) was
calculated using the formula: maximum heart rate (HRmax) – resting heart rate (HRrest)
(CSEP). Maximum heart rate was equivalent to 220 – age (CSEP). Resting heart rate
(RHR; beats per minute) was taken at baseline. After 11-15 hours of smoking abstinence,
resting heart rate can drop by approximately 8.5 beats per minute (Perkins, Epstein,
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Stiller, Marks, & Jacob, 1989). Resting heart rate was taken before abstinence because it
is an indicator of normal heart rate. The calculation for 40% HRR was: [(HRmax – HRrest)
X .4] + HRrest (CSEP). The calculation for 68% HRR was: [(HRmax – HRrest) X .68] +
HRrest (CSEP). Heart rate (HR) was monitored using a Polar RS100 heart rate monitor.
Passive sitting. The control condition involved sitting on a chair in the testing
facility for 10 minutes. Participants were alone in a room, had minimal contact with the
investigator, and were not discouraged from reading.

Procedure
Ethics approval was granted by the University of Western Ontario Research
Ethics Board for Health Sciences Research Involving Human Subjects (REB #18109,
Appendix A). Participants were recruited via several sources. Posters were placed on the
university campus, in the university newspaper, at the Middlesex London Health Unit,
and at Kelloggs® Canada (Appendix A). In addition, electronic advertisements were
mailed to students at the University of Western Ontario (UWO) and employees of the
London Health Sciences Centre (LHSC).
A flow diagram of the design and procedure is presented in Figure 1. Eligibility
was determined by an initial telephone or e-mail screen, followed by one screening visit
(Session 1). Subsequent to an expression of interest, participants were contacted by
phone or e-mail and asked their age, smoking status (e.g., number of cigarettes per day),
smoking history (e.g., number of years as a regular smoker, previous quit attempts), and
current physical health. Participants were screened with the PAR-Q (CSEP, 2002).
Participants who answered “yes” to any question on the PAR-Q were required to seek
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physician approval before participating in this study. The study involved participants
completing two visits (Session 1 and Session 2) at the Exercise and Health Psychology
Laboratory (EHPL; www. ehpl.uwo.ca) at the University of Western Ontario (London,
Ontario).
Baseline assessments (Session 1) included: (1) verification of smoking status; (2)
smoking topography; and (3) other variables. Smoking status was verified using the
piCO+™ Smokerlyzer® carbon monoxide (CO) monitor (Bedfont Scientific Ltd., Kent,
England). A carbon monoxide reading of 10 parts per million (ppm) was the threshold of
inclusion (as used in previous research; Faulkner et al., 2010) (M =16.00, SD=7.56).
First, participants completed the demographic questionnaire. Participants then completed
an assessment battery, including: (1) International Physical Activity Questionnaire
(IPAQ; Craig et al., 2003); (2) Fagerstrom Test for Nicotine Dependence (FTND;
Heatherton et al., 1991); and (3) desire to smoke (Tiffany & Drobes, 1991). All
questionnaires can be referred to in Appendix B.
Next, participants were trained on the proper use of the Clinical Research Support
System (CReSS) Pocket smoking topography device (Plowshare Technologies ®,
Borgwaldt KC. Inc., Virginia, USA). Participants were briefed on proper use of the
CReSS Pocket and were instructed to smoke the cigarette as normal. Subsequently,
participants went outside of the laboratory building and smoked a cigarette (preferred
own brand) using the CReSS Pocket. Participants were provided with an instruction
sheet while in possession of the device. In addition, participants were required to bring
their preferred brand of cigarette to all study procedures. To conclude, participants
completed the acceptability questionnaire. Session 1 took roughly 45 minutes to
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complete.
Participants who satisfied all inclusion and exclusion criteria were randomized to
one of two conditions: experimental (moderate intensity exercise) or control (passive
sitting) (Figure 1). The participants were randomized to maximize group equivalency. If
willing to participate (voluntary basis), eligible participants provided informed consent.
Session 2 was scheduled for one week subsequent to baseline (M = 7.42 days, SD
= 2.45). To control for within subject variation in desire to smoke, Session 2 was
scheduled for the same time of day as baseline (Mtime =1.47 hours, SD =1.81). Preceding
Time 2, participants were directed to abstain from smoking for a minimum of 18 hours
(Mtime = 14.8 hours, SD = 4.95). Temporary smoking abstinence was verified using the
piCO+™ Smokerlyzer® carbon monoxide (CO) monitor. A breath carbon monoxide
level of less than 10 ppm was taken as evidence of smoking abstinence (as used in
previous research; Daniel et al., 2006; Ussher et al., 2001) (M = 6.03, SD = 6.78). Desire
to smoke (Tiffany and Drobes, 1991) was assessed one minute pre-condition: exercise or
passive sitting. Subsequently, all participants completed their allocated ten minute
condition. Desire to smoke (Tiffany & Drobes, 1991) was assessed one minute postcondition. Participants then left the laboratory building to smoke a cigarette (preferred
own brand) using the CReSS Pocket (Time 2a). Upon return to the laboratory,
participants in both conditions sat passively for 30 minutes. Subsequent to the 30 minute
waiting period, participants once again left the laboratory to smoke a cigarette (preferred
own brand) using the CReSS Pocket (Time 2b). This smoking protocol was followed to
assess whether topography effects found at Time 2a would carry over to Time 2b. The
acceptability questionnaire was completed to conclude the study. Session 2 took roughly
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90 minutes to complete. All participants were debriefed at the end of Session 2.
Data from this study were entered into a Microsoft Excel database at the host
institution’s laboratory and extracted into IBM SPSS Statistics (Version 19) for analysis.
For data security, all computers at the EHPL are linked to the host institutions’ LEGATO
backup system.
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Figure 1. Flow diagram of design and overall procedure
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Power Calculation
The current study was intended as a pilot study; hence no formal power
calculation was computed.

Statistical Analyses
To assess group equivalency at baseline (Session 1), independent samples t-tests
were conducted to compare the demographic markers, other measures, and the primary
outcome variables (i.e., puff count, puff volume, puff duration, inter-puff interval, total
duration). An independent samples t-test was also conducted to assess group equivalency
for smoking abstinence (hours) prior to Session 2.
Desire to smoke was the manipulation check, and a repeated measures ANOVA
was conducted to identify a condition (exercise vs. passive sitting) by time (pre- and postcondition) interaction effect. The relationship between desire to smoke and topography
variables at Session 2a and Session 2b was investigated using Pearson product-moment
correlation coefficients.
For the topography variables, a series of condition (exercise vs. passive sitting) by
time (baseline, Session 2a, and Session 2b) repeated measures ANOVAs were conducted.
Also, a series of one-way repeated measures ANOVAs were conducted to identify time
effects (baseline, Session 2a, and Session 2b) using only the participants in the exercise
condition who showed a desire to smoke reduction post-exercise.
The relationship between subjective acceptability and topography variables at
baseline (Session 1) was investigated using Pearson product-moment correlation
coefficients (Table 7).
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The level of significance was accepted at p < .05 for all tests (Tabachnick &
Fidell, 1996). Effect sizes (ή2) accompany all reported findings. In accordance with
Cohen (1988), 0.01 is a small effect size, 0.06 is a moderate effect size, and 0.14 is a
large effect size. Pearson product-moment correlation coefficients (r) of .10 to .29, .30 to
.49, and .50 to 1.0 denote correlations of small, medium, and large, respectively (Cohen,
1988).
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Results
Treatment of Data
Missing data. A participant who did not complete an outcome measure entirely
was excluded on an analysis by analysis basis. Tabachnick and Fidell (1996) considered
this the most conservative way to treat missing data. This occurred 6 times in total at
baseline (Session 1). On the demographic questionnaire, four participants did not
complete height and weight. One participant did not complete the household smoking
question. Last, one participant did not complete the desire to smoke scale at baseline
(Session 1). Missing data did not occur at Session 2.
Outliers. Outliers were identified based on inspection of the Boxplot. A data
point was defined as an outlier if it extended more than 1.5 box-lengths from the edge of
the box. A data point was defined as an extreme outlier if it extended more than 3 boxlengths from the edge of the box. The outliers and extreme outliers were removed from
the subsequent analyses. Outliers were found for the subsequent demographic
characteristics: BMI, number of cigarettes per day, age of first cigarette, and total MET
min/week. Outliers were also found for the carbon monoxide reading at Session 2. At
Session 1, outliers were found for the subsequent outcome variables: puff count, mean
puff duration, mean inter-puff interval, and total duration. At Session 2a, outliers were
found for the subsequent topography variables: puff count, and mean inter-puff interval.
Last, at Session 2b, outliers were found for the subsequent topography variables: puff
count, mean inter-puff interval, and total duration.
Assumptions of statistical techniques. The dependent variables that were
studied were continuous (interval), and observations were independent. The data were

31

obtained using a random sample from the population. Normality was assessed by
skewness and kurtosis values. The Kolmogorov-Smirnov statistic assessed the normality
of the distribution of scores. Last, histograms were used to check the shape of the
distribution.
Repeated measures ANOVAs were checked for the assumptions of homogeneity
of variances (homoscedasticity) and homogeneity of inter-correlations (sphericity).
Levene’s test for equality of variances and Box’s M statistic were used to check the
assumptions respectively. Upon examination of the tests, the assumptions were not
violated.
Last, bivariate correlations were checked for the assumptions of linearity and
homoscedasticity. This was determined by visual inspection of the distribution of data
points in the scatterplots.
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Flow of Participants
The flow of participants is presented in Figure 2.

Figure 2. Flow of participants through the study.
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Group Equivalency at Baseline
There was a significant difference in age for exercise (M= 39.19, SD= 13.65) and
passive (M= 47.86, SD= 10.64) conditions; t (41) = -2.584, p = .014, ή2 = .374. There
was a significant difference in total years smoked for exercise (M= 19.26, SD= 13.05)
and passive (M= 28.32, SD= 12.71) conditions; t (41) = -2.305, p = .026, ή2 = .339.
There was a significant difference in regular years smoked for exercise (M= 16.14, SD=
12.53) and passive (M= 24.68, SD= 14.34) conditions; t (41) = -2.097, p = .041, ή2 =
.311. There was a significant difference in nicotine dependence (FTND) for exercise
(M= 4.10, SD= 1.92) and passive (M= 5.82, SD= 1.99) conditions; t (41) = -2.885, p =
.054, ή2 = .411. There was a significant difference in expired carbon monoxide (CO) for
exercise (M= 13.29, SD= 6.00) and passive (M= 18.59, SD= 8.10) conditions; t (41) = 2.448, p = .019, ή2 = .357. There was no significant difference between groups for the
remaining variables: BMI, age of first cigarette, number of cigarettes per day, total MET
min/week, and time since last cigarette (Table 2).
There was no significant difference in number of hours abstained for exercise (M=
13.47, SD= 5.91) and passive (M= 16.61, SD= 2.69) conditions; t (26) = -1.852, p = .079,
ή2 = .341.
There was no significant difference in desire to smoke at baseline for exercise
(M= 5.61, SD= .98) and passive (M= 6.05, SD= .90) conditions; t (38) = -1.461, p = .152,
ή2 = .231.
For the primary outcome variables, there was no significant difference in puff
volume for exercise (M= 53.08, SD= .18.34) and passive (M= 59.38, SD= 17.31)
conditions; t (40) = -1.147, p = .258, ή2 = 178. There was no significant difference in
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puff duration for exercise (M= 1.67, SD= .51) and passive (M= 1.61, SD= .50) conditions;
t (40) = -1.147, p = .360, ή2 = .057. Also, there was no significant difference in total
cigarette duration for exercise (M= 3.88, SD= .87) and passive (M= 3.93, SD= .93)
conditions; t (38) = .330, p = .360, ή2 = .053. But, there was a significant difference in
puff count for exercise (M= 15.00, SD= 5.22) and passive (M= 10.83, SD= 2.73)
conditions; t (37) = 3.188, p = .003, ή2 = .464. Last, there was a significant difference in
inter-puff interval for exercise (M= 12.78, SD= 4.41) and passive (M= 17.70, SD= 7.89)
conditions; t (37) = -2.525, p = .016, ή2 = .371.
For the acceptability variables, there were no significant differences between
groups at baseline for alter puff count, puff volume, puff duration, IPI, and total duration.
Also, there were no significant differences between groups at baseline for reduce
smoking enjoyment, affect cigarette taste, increase smoking difficulty, and increase
smoking awareness (Table 6).
The variables that were not equivalent at baseline were considered a potential
covariate in the subsequent analyses. The assumptions of linearity, homogeneity of
variances, and homogeneity of regression slopes were checked. Each demographic
marker violated at least one of the assumptions. Therefore, the markers were not
considered as covariates in the subsequent analyses. Baseline values for puff count and
inter-puff interval satisfied the assumptions. These values were used as covariates in the
subsequent analyses.
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Table 2
Demographic characteristics and smoking status at baseline
Experimental Group

Control Group

21

22

6/15

3/19

Number of participants
Male/Female
Variable

M

SD

M

SD

Age (years)

39.19

13.65

47.86

10.64

BMI (kg/m2)

25.21

5.89

27.42

6.37

2603.33

2667.91

2053.19

2190.39

Cigarettes per day

17.29

8.39

19.23

9.92

Fagerström test of nicotine
dependence

4.10

1.92

5.82

1.99

Age of first cigarette

15.62

8.52

13.68

3.72

Number of years smoking

19.26

13.05

28.32

12.71

Number of regular years
smoking

16.14

12.53

24.68

14.34

Baseline (Session 1)

13.29

6.00

18.59

8.10

Pre- condition (Session 2)

6.13

5.79

5.93

7.94

Length of smoking abstinence (hr.)

13.47

5.91

16.61

2.69

Demographics:

Physical activity (IPAQ)
Smoking status

Smoking history

Expired carbon monoxide (ppm)

Note: BMI= Body Mass Index, IPAQ= International Physical Activity Questionnaire,
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Manipulation Check
Desire to smoke. Desire to smoke was selected as the manipulation check
because it is the most strong and consistently reported outcome in the acute literature
(Taylor et al., 2007). Outliers were found for desire to smoke at baseline, Session 2a, and
Session 2b. A significant effect for time (F [2, 24] = .609, p = .003, ή2 = .391) was
found. The time by group interaction was also significant (F [2, 24] = .670, p = .008, ή2
= .330) (Figure 3). Overall, mean desire to smoke decreased to a greater degree for the
exercise condition (Table 3).
Relationships. Bivariate correlations were used to examine the relationship
between post-condition desire to smoke and the topography variables at Session 2a
(Table 4a) and Session 2b (Table 4b). There was a strong, positive correlation between
post-condition desire to smoke and total duration of cigarette at Session 2a. There was a
strong, positive correlation between post-condition desire to smoke and total duration at
Session 2b.
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Table 3
Mean and standard deviations (SD) of desire to smoke by condition and time
Whole Sample
Variable

Exercise Condition

Passive Condition

Mean

SD

Mean

SD

Mean

SD

Baseline

5.85

.95

5.61

.98

6.05

.90

Pre-condition

6.27

1.01

5.94

1.24

6.64

.50

Post-condition

5.10

1.88

4.06

1.88

6.38

.77

Desire to smoke
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Table 4a
Correlations for desire to smoke post-condition and outcome variables at Session 2a

Desire to smoke
Post-condition


Puff count
2a

Puff volume
2a

Puff duration
2a

IPI 2a

Total duration 2a

-.029

.134

-.087

.228

.430*

Correlation is significant, p < .05

Table 4b
Correlations for desire to smoke post-condition and outcome variables at Session 2b

Desire to smoke
Post-condition


Puff count
2b

Puff volume
2b

Puff duration
2b

.042

.209

.174

Correlation is significant, p < .05

IPI 2b Total duration 2b
.285

.405*
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8

Desire to smoke

7

6

5

4

3
Baseline

Pre-condition

Post-condition

Assessment Time
Experimental
Control

Figure 3. Mean desire to smoke at baseline, pre-condition, and post-condition.
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Descriptive Statistics of the Primary Outcome Variables
The descriptive statistics (mean, standard deviations (SD)) for the outcome
variables (puff count, puff volume, puff duration, IPI, and total duration) by condition
and time are presented in Table 5.
Table 5
Mean and standard deviations (SD) of outcome variables by condition and time
Variable

Whole Sample

Exercise Condition

Passive Condition

Mean

SD

Mean

SD

Mean

SD

Baseline

13.08

4.70

15.00

5.22

10.83

2.73

Time 2a

12.86

4.80

14.00

5.97

11.46

2.33

Time 2b

12.21

3.60

13.53

4.27

10.69

1.80

Baseline

56.23

17.90

53.08

18.34

59.38

17.31

Time 2a

56.81

16.92

55.99

17.08

57.70

17.29

Time 2b

55.60

18.16

52.94

17.37

58.44

19.15

Baseline

1.64

.50

1.67

.51

1.61

.50

Time 2a

1.65

.46

1.71

.53

1.60

.37

Time 2b

1.66

.45

1.64

.51

1.68

.41

Baseline

15.36

6.86

12.78

4.41

17.70

7.89

Time 2a

16.56

6.76

15.42

6.78

17.86

6.74

Time 2b

16.16

8.28

13.57

5.19

18.75

10.03

Baseline

3.90

.89

3.88

.87

3.93

.93

Time 2a

4.00

1.19

3.85

1.29

4.15

1.09

Time 2b

3.69

1.12

3.60

1.14

3.78

1.14

Puff count

Puff volume (ml)

Puff duration (sec.)

IPI (sec.)

Total duration (min.)

Note: IPI= Inter-puff interval, SD= standard deviation.
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Group Differences
Puff count. Puff count at baseline was used as a covariate in this analysis.
Preliminary checks were conducted to ensure there was no violation of the assumptions
of normality, linearity, homogeneity of variances, and homogeneity of regression slopes.
After adjusting for baseline values, the difference between groups for puff count at Time
2b was non-significant (F [1, 25] = .886, p = .356, ή2 = .034) (Figure 4). After adjusting
for baseline values, the difference between groups for puff count at Time 2b was nonsignificant (F [1, 24] = .300, p = .589, ή2 = .012) (Figure 4).
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Time 2a
Assessment Time
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Control

Figure 4. Mean puff count at baseline, Time 2, and Time 2b.

Time 2b
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Puff volume. The effect for time was non-significant (F [2, 28] = .939, p = .414,
ή2 = .061), and the time by group effect was non-significant (F [2, 28] = .889, p = .192,
ή2 = .111) (Figure 5).
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Time 2b
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Figure 5. Mean puff volume (ml) at baseline, Time 2a, and Time 2b.
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Puff duration. The effect for time was non-significant (F [2, 28] = .986, p =
.820, ή2 = .014). The time by group interaction was also non-significant (F [2, 28] =
.902, p = .238, ή2 =.098) (Figure 6).

46

1.85
1.80

Puff duration (sec.)

1.75
1.70
1.65
1.60
1.55
1.50
1.45
Baseline

Time 2a

Time 2b

Assessment Time
Experimental
Control

Figure 6. Mean puff duration (sec.) at baseline, Time 2a, and Time 2b.
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Inter-puff interval. Inter-puff interval at baseline was used as the covariate in
this analysis. Preliminary checks were conducted to ensure there was no violation of the
assumptions of normality, linearity, homogeneity of variance, and homogeneity of
regression slopes. After adjusting for baseline values, the difference between groups for
inter-puff interval at Time 2a was non-significant (F [1, 26] = .023, p = .881, ή2 = .001)
(Figure 7). After adjusting for baseline values, the difference between groups for interpuff interval at Time 2b was non-significant (F [1, 26] = .710, p = .407, ή2 = .027)
(Figure 7).
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Figure 7. Mean IPI (sec.) at baseline, Time 2, and Time 2b. IPI = inter-puff interval.
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Total duration. The effect for time was non- significant (F [2, 26] = .865, p
=.379, ή2 =.135). The time by group interaction was also non-significant (F [2, 26] =
.759, p =.165, ή2 = .055) (Figure 8).
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Figure 8. Mean total duration (min.) at baseline, Time 2a, and Time 2b.
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Ancillary Analyses for Desire to Smoke Reduction
The subsequent analyses were conducted using only participants in the exercise
condition who reported a minimum one point desire to smoke reduction post-condition
(n = 11).
Puff count. For puff count, the one-way repeated measures ANOVA showed a
non-significant effect for time (F [2, 9] = .740, p = .258, ή2 = .260). However, the effect
was large, and visual inspection of the data indicated that puff count decreased after
exercise.
Puff volume. For puff volume, the one-way repeated measures ANOVA showed
a non-significant effect for time (F [2, 10] = .711, p = .182, ή2 = .289). The effect was
large, and visual inspection of the data indicated that puff volume increased after
exercise.
Puff duration. For puff duration, the ANOVA showed a non-significant effect
for time (F [2, 10] = .876, p = .517, ή2 = .124). The effect was large, and visual
inspection of the data indicated that puff duration increased after exercise.
IPI. For IPI, the ANOVA showed a non-significant effect for time (F [2, 9] =
.675, p = .170, ή2 = .325). However, the effect was large, and visual inspection of the
data indicated that IPI increased after exercise.
Total duration. For total duration, the ANOVA showed a non-significant effect
for time (F [2, 8] = .674, p = .674, ή2 = .094). However, the effect was moderate-large,
and visual inspection of the data indicated that total duration decreased after exercise.
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Acceptability of the CReSS Pocket

Table 6
Mean and standard deviations (SD) of acceptability variables by condition and time
Acceptability Item

Alter puff count
Baseline
Session 2
Alter puff volume
Baseline
Session 2
Alter puff duration
Baseline
Session 2
Alter IPI
Baseline
Session 2
Alter total duration
Baseline
Session 2
Reduce smoking enjoyment
Baseline
Session 2
Affect cigarette taste
Baseline
Session 2
Increase smoking difficulty
Baseline
Session 2
Increase smoking awareness
Baseline
Session 2

Note: IPI = inter-puff interval

Whole Sample

Exercise Condition

Passive Condition

Mean

SD

Mean

SD

Mean

SD

49.53
47.10

27.74
34.76

40.00
46.88

28.98
37.54

44.09
47.33

27.02
32.83

49.53
52.58

31.54
30.98

44.76
50.63

33.11
32.55

54.09
54.67

30.03
30.21

49.53
50.97

29.35
31.34

43.33
51.88

31.68
35.82

55.45
50.00

26.32
26.99

43.95
48.71

27.44
33.94

43.33
46.25

30.01
36.31

44.55
51.33

25.40
32.26

40.70
52.58

27.81
34.35

40.48
50.63

27.83
37.14

40.91
54.67

28.44
32.26

62.79
61.29

28.81
31.17

58.57
58.13

30.54
34.10

66.81
64.67

27.15
28.50

52.56
48.06

33.03
31.56

47.14
38.75

35.52
29.18

57.73
58.00

30.38
31.89

53.26
50.65

34.14
32.14

44.30
44.38

37.09
35.40

61.81
57.33

29.38
27.89

60.93
62.90

32.57
32.88

57.62
59.38

37.00
37.14

64.09
66.67

28.23
28.45
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Table 7
Correlations for acceptability and topography variables at Time 1
Puff
count 1
.043

Puff
volume 1
.004

Puff
duration 1
.031

-.061

Total
duration 1
.051

Alter puff volume

-.011

.004

.059

-.124

-.022

Alter puff duration

-.130

-.051

.087

.150

.093

Alter IPI

-.049

-.041

.040

-.156

-.091

Alter total duration

-.021

-.088

.039

-.027

.093

Reduce smoking enjoyment

-.048

.182

.289

-.081

-.115

Affect cigarette taste

.024

.127

.298

-.138

-.044

Increase smoking difficulty

.114

.109

.235

-.033

-.003

Increase smoking awareness

.175

-.150

.078

-.141

-.015

Alter puff count



Correlation is significant, p < .05

IPI 1
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Chapter Three: Discussion
Effect of Exercise on Smoking Topography
This pilot study investigated the effect of an acute bout of exercise on objective
smoking topography. It was hypothesized that compared to a passive condition, there
would be positive changes in topography subsequent to exercise. The current study was
designed to overcome limitations of previous research (Faulkner et al., 2010).
Overall, topography differences between conditions and across assessment times
were negligible. To begin, subsequent to controlling for baseline, the between group
differences effect for puff count was small and non-significant. The exercise condition
showed decreased puff count, whereas the passive increased puff count. Faulkner and
colleagues (2010) showed a similar trend for reduced count subsequent to exercise.
Second, with respect to puff volume, the effect was moderate-large and nonsignificant. There was a marginal increase in volume after exercise, whereas volume
decreased after sitting for the first cigarette. The trend is not consistent with Faulkner
and colleagues (2010) and was contrary to the hypothesis. Volume was in the
hypothesized direction for the subsequent cigarette (Time 2b).
Third, the results for puff duration showed a moderate, non-significant effect.
The pattern found was similar to puff volume, and hence not consistent with the work of
Faulkner and colleagues (2010). Perhaps the effect of exercise on volume and duration is
delayed; such that, time is required to see a positive change on these indices.
Fourth, with respect to inter-puff interval the effect was small and non-significant.
The time between puffs increased for the exercise condition, compared to baseline. The
pattern is not consistent with Faulkner and colleagues (2010) which found reduced inter-
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puff interval.
Last, with respect to total duration, the effect was small and non-significant.
Compared to baseline, total duration decreased subsequent to exercise, whereas duration
increased after sitting. Despite being under-powered, the trend is congruent with the
hypothesis.
Compared to baseline, there was a trend for decreased puff count and total
duration subsequent to exercise. Also, inter-puff interval increased subsequent to
exercise. The patterns indicate harm reduction. However, the volume and duration of
each puff increased. In essence, the outcome was a null result. Taking bigger and longer
puffs to offset decreased puff count is a form of compensation. Past research showed
evidence of compensatory smoking when cigarettes with a lower nicotine yield were used
(Strasser, Lerman, Sanborn, Pickworth, & Feldman, 2007). Future exercise and
topography research ought to consider the nicotine yield of the cigarettes that participants
smoke during the study. Also, total puff volume is a key determinant of tobacco
exposure (Zacny et al., 1987). Hence, it should be considered in future research.
The findings of this study support the null hypothesis. But, the question is why?
Why are the current findings not congruent with those reported by Faulkner and
colleagues (2010)? One explanation for the inconsistent findings between studies is
sampling. Specifically, there are demographic and smoking history differences between
the samples used in the respective studies. For instance, compared with the sample in the
Faulkner et al. (2010) study, the sample of this study was older (Mage = 43.1 vs. 24.6),
smoked more cigarettes per day (M= 18.3 vs. 15.2), and had likely smoked for a greater
number of years (M= 23.8 vs. unknown). In addition, the current sample was 79%
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female. In contrast, the sample of Faulkner and colleagues (2010) was 58% males. As
mentioned previously, males and females smoke a cigarette differently. Taken together,
the differences suggest that topography was less malleable for the sample in the current
study compared to the sample in the Faulkner and colleagues (2010) study.
There were also methodological differences amongst the two studies. First, the
current study used a 10-minute bout of moderate intensity exercise on a treadmill. The
heart rate zone, based on the pre-abstinence resting heart rate value, was unique to each
participant. In contrast, Faulkner and colleagues (2010) used a 10-minute bout of brisk
walking. At this stage of research, the impact of exercise intensity and/or duration (if
any) on smoking topography is unknown. Second, the mean length of smoking
deprivation in the current study was 14.8 hours, compared to 8.4 hours in the Faulkner
and colleagues (2010) study. Pre-condition desire to smoke was higher in this study, but
the impact of deprivation length on topography is unknown. Last, the two studies used
the CReSS Pocket to measure topography. All topography measurements are limited, to
some degree, by the false act of smoking with a mouthpiece (Williams et al., 2011).
Previous research has found that mouthpiece-based devices increase smoking difficulty,
reduce smoking enjoyment, and affect cigarette taste (Blank et al., 2009). Although the
CReSS Pocket allows for measurement of complex smoking markers, the device may be
a limiting factor. However, this is unlikely in the current study given the neutral response
among participants regarding the acceptability of the device.
Finally, there are design differences between the two studies. Faulkner and
colleagues (2010) used a within-subject design. In contrast, the current study was a
randomized controlled trial (RCT). A discussion of the strengths and limitations of these
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designs is necessary. To begin, random allocation to a condition minimized the influence
of known and unknown confounders (Peat, 2001). Hence, a randomized controlled trial
“provides the highest level of evidence for the effects of an intervention and for
causation” (Peat, 2001). A randomized controlled trial was the most appropriate design
for this research question. The strengths of a within-subject design include: (a) power;
and (b) reduction of error variance associated with individual difference. Using a withinsubject design, Faulkner and colleagues (2010) showed that a bout of brisk walking may
positively change topography. While this outcome was encouraging, the design of the
current study is stronger and the evidence should be appraised accordingly.

Effect of exercise on desire to smoke
It is a well-established finding that an acute bout of low to moderate intensity
exercise regulates desire to smoke in temporarily abstinent smokers (Taylor et al., 2007;
Roberts et al., 2012). The findings from the present study will add to the existing body of
literature. Further, the present study examined the relationship between desire to smoke
and topography markers.
In the present study, the condition by time effect was significant. Participants
reported lower desire to smoke in the exercise condition compared to the passive sitting
condition. In congruence with past research (e.g. Daniel et al., 2004; Faulkner et al.,
2010), this study demonstrates that an exercise bout of short duration and moderate
intensity reduces desire to smoke, compared to a passive sitting condition.
Post-condition desire to smoke was correlated with the topography variable, total
duration. The correlation was significant at Time 2a and Time 2b; as post-condition
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desire to smoke increased, total duration of cigarette increased. Despite being nonsignificant, desire to smoke was also correlated with puff volume and duration; as desire
to smoke increased, volume and duration increased. Also non-significant, desire to
smoke was correlated with inter-puff interval (IPI); as desire to smoke increased, the time
between puffs increased. The correlation of post-condition desire to smoke to smoking
topography should be further examined. Faulkner and colleagues (2010) investigated the
relationship between craving reduction and topography markers. This research could be
refined with the use of a between-subject design.

Ancillary Analyses for Desire to Smoke Reduction
A series of post-hoc tests were conducted once the main findings were found to be
non-significant. The aim was to examine topography change using only a sub-group of
participants in the exercise condition who reported a desire to smoke reduction postcondition. It was postulated that participants in the exercise condition who reported a
desire to smoke reduction would show a more pronounced change in smoking
topography. A series of one-way repeated measures ANOVAs were conducted. The
time effect for topography (i.e., puff count, puff volume, puff duration, inter-puff
interval, and total duration) was non-significant.
The sub-group was under-powered to detect a change in topography. However,
upon visual inspection of the data, a number of trends were present. First, the number of
puffs was reduced subsequent to exercise. On average, this sub-group took 1.5 less puffs
compared to baseline. Second, volume increased for the first cigarette after exercise, but
volume returned to baseline for the subsequent cigarette. Puff volume is correlated with
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puff duration (r = .628), thus, it follows that puff duration followed a similar trend.
Third, IPI increased for the first cigarette after exercise. On average, the time between
puffs increased by 1.5 seconds. This trend did not hold for the second cigarette. Fourth,
the total duration decreased subsequent to exercise. On average, the sub-group spent 12
fewer seconds with the first cigarette, compared to baseline. The trends for this subgroup were congruent with the previously reported patterns of the total sample. Overall,
the results do not change dramatically when assessing only participants in the exercise
group who reported a lower desire to smoke post-condition.
A desire to smoke reduction may be needed to change objective topography. But,
it is not known what amount of reduction is needed. The current study included
participants who reported a minimum one point reduction of desire to smoke. This
criterion was chosen because the sample size was small. A greater reduction of desire to
smoke (e.g., 3 point reduction on 7 point scale) may be required to change topography.
In future trials, a desire to smoke reduction that is relative to pre-condition values should
be considered. Future research also ought to consider if a critical level of desire to smoke
must be reached to see topography change. The aforementioned questions should be
honed in on in the early stage of exercise and topography research.

Strengths and Limitations
The present study had a number of strengths. First, the CReSS Pocket was used
to measure topography. The CReSS Pocket is a portable, user-friendly device which
allowed for measurement in a “natural” setting. Second, the setting where topography
was assessed was held constant. A past study showed that topography can change across
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social and non-social settings (Miller, Frederiksen, & Hosford, 1979). This study was
designed to minimize natural topography change. Third, the design was strong; valid
assessments were used, subjects were randomized according to stratification criteria,
group allocation was concealed, and the randomization criteria minimized contamination
of extraneous factors.
It is important to acknowledge the limitations of the current study. First, this
study was a pilot study and was under-powered to detect a difference in smoking
topography. Research with a larger sample size may contribute to the findings. Second,
random allocation was based on a number of stratification criteria; yet, there were
significant differences between the exercise and passive condition (e.g., age, FTND, puff
count, inter-puff interval). Therefore, the groups were not comparable on known and
unknown factors that may have influenced the findings. Third, the sample of this study
was 79% female. Eissenberg and colleagues (1999) demonstrated that sex effects
topography. The sex profile of the current study does not represent the general smoking
population. Last, the intervention was a supervised exercise session in a laboratory. The
dose of exercise was closely monitored, which strengthened the internal validity of this
study. But, it is unknown how the findings would generalize to a natural environment.

Future Directions
The present study did not find support that a solitary session of exercise alters
smoking topography. Future research should revise the exercise dose (i.e., type, time,
intensity) in order to assess what exercise dose is most effective. Also, future work using
a larger sample may overcome the issue surrounding lack of power and disparity between
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groups at baseline. Other limitations identified above should also be addressed.
Sub-groups of smokers should also be examined. Ones level of nicotine
dependence and/or gender may have an effect on topography. Also, future research
should use a less active sample (< 600 MET – minutes/week). A session of exercise may
be more effective for this sub-group. Examination of topography in a sub-group of
smokers who experience extreme desire to smoke relief may also be beneficial. This
research may assist in delineating factors that affect exercise-related topography change,
and ultimately harm reduction.
Past research found that the CReSS Pocket influenced subjective measures of
smoking (e.g., increased smoking difficulty) (Blank et al., 2009). There is limited
research on smokers’ perceptions of the CReSS Pocket and its influence on smoking
behavior. Future work should compare self-reported acceptability of the CReSS Pocket
to objective smoking topography.
There are logistical concerns associated with use of the CReSS Pocket (e.g., cost).
The past evidence for a delay in ad libitum smoking subsequent to exercise (Reeser,
1983; Taylor & Katomeri, 2007; Thayer et al., 1993) is more fruitful than the evidence
presented here for topography change. Once a person returns to smoking, the change in
objective smoking topography is non-significant. Exercise as a harm reduction strategy
may therefore only apply to delaying ad libitum smoking and ultimately reducing the
number of cigarettes per day.
Smokers’ motives for smoking and stage of readiness to quit should also be
considered. A smoker who is unwilling to quit may smoke in a different way than a
smoker who plans to quit in the near future. Also, a smoker may lower their rate of
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consumption prior to a quit date. But, it is unknown if a change in topography occurs
concurrently with smoking reduction. It would also be interesting to examine topography
in relation to ones smoking motives. For example, an exercise session may alter
topography to a greater degree in people who smoke for pleasure versus those who smoke
to cope with stress. This work would provide insight into factors that influence exerciserelated smoking topography change.
A solitary session of exercise can decrease desire to smoke. Desire to smoke is
related to smoking topographical indices (i.e., total duration), and may also be the
mechanism behind smoking topography change. But, from this study it is not clear if
topography changes are more pronounced after a desire to smoke reduction. This study
was under-powered, therefore future research is needed. Future research should also
consider the critical level of reduction needed. It is not likely that a control group will
report a desire to smoke reduction. Therefore, investigating this issue may be a
challenge.

General Summary and Conclusions
There are ‘hardened’ smokers who do not want to quit or find it very difficult to
quit. ‘Hardened’ smokers will continue to smoke regardless of the life-threatening
consequences. Moreover, the success rate of unaided attempts is 3-5% (Hughes et al.,
2004). A harm reduction approach, which minimizes the risk of morbidity and mortality,
is well-suited for this population. The general objective of this study was to examine if
exercise, as it relates to smoking behavior change, is an efficacious harm reduction
strategy. To do this, the effect of an acute bout of exercise on objective smoking
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topography was examined. A sophisticated assessment device, the CReSS Pocket, was
used. The present study provides the first randomized controlled trial evidence that
exercise-related smoking topography change is small. Hence, the efficacy of exercise as
a harm reduction strategy is not supported. Moving forward, in order to help ‘hardened’
smokers, a top priority of researchers and health care providers ought to be the
development and evaluation of effective harm reduction strategies. By addressing the
limitations of this research, the role of exercise as a harm reduction strategy can be better
understood.
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LETTER OF INFORMATION
Study Title: Does an acute bout of exercise affect smoking satisfaction?
Principal Study Investigator:
Harry Prapavessis, Ph.D. (School of Kinesiology, Western University)
Co-Investigators:
Terri Schneider, B.A. (School of Kinesiology, Western University)
Stefanie De Jesus, Ph.D. (cond.), M.A., B.Sc. (School of Kinesiology, Western
University)
You are being invited to participate in a research study looking at the effects of a short
period of exercise on smoking behaviour. This is a randomized control trial (a type of
research study), which includes eligible volunteers who choose to take part. Please take
your time to make a decision, and discuss this proposal with your personal doctor, family
members and friends as you feel inclined. The purpose of this letter is to provide you
with the information you require to make an informed decision on participating in this
research. This letter contains information to help you decide whether or not to participate
in this research study. It is important for you to know why the study is being conducted
and what it will involve. Please take the time to read this carefully and feel free to ask
questions if anything is unclear or there are words or phrases you do not understand. We
are asking you to take part because you are an adult between 18 and 64 years of age who
smokes.
Purpose of the study
Exercise has been shown to help with traditional cessation strategies. A single bout of
exercise, low to moderate in intensity, can help regulate cravings, withdrawal symptoms
and smoking topography. Smoking topography refers to the measurement of smoking
behaviour, which includes puff volume, maximum puff velocity, inter-puff interval, puff
duration, number of puffs per cigarette, and the time to smoke a single cigarette.
The primary objective of this study is to examine the effects of an acute bout of moderate
intensity exercise on smoking satisfaction and smoking behaviour (smoking topography)
following a period of smoking abstinence. The second purpose of this study is to assess
the influence of nicotine metabolism rate (how quickly your body breaks down nicotine)
on smoking satisfaction and topography.
Participants
One hundred participants will be asked to take part in this research. To be eligible to
participate, you must meet the following criteria: 18 and 64 years of age, smoke 10 or
more cigarettes per day for more than 2 years, have not been engaged in a serious quit
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attempt in the last six months, must not be suffering from an illness (e.g. cold) that would
affect your typical smoking behavior, do not have a medical condition that prevents you
from exercising, not be pregnant or intending on becoming pregnant. You must also be
able to read and write in English and have a telephone or e-mail account that the
investigators can contact you at.
Research Procedure
If you choose to take part in this study, you will be asked to complete three study
components: A) the first laboratory session, B) abstain from smoking, C) the second
laboratory session.
The laboratory sessions will be held at the Exercise and Health Psychology Laboratory
(EHPL) at The University of Western Ontario (UWO). The EHPL is located in Room
408 of the Labatt Health Sciences Building. Prior to the first meeting you will be asked
to complete the Physical Activity Readiness Questionnaire (PAR-Q). The pre-screening
period, including the completion of the PAR-Q will take approximately 20 minutes to
complete. Each laboratory meeting will take approximately 75 minutes.
A) First laboratory session
During your first laboratory session, you will complete a questionnaire package (see Item
1) and the following information will be collected: resting heart rate (see Item 2), weight,
height, breath carbon monoxide levels (see Item 3) and saliva samples (see Item 4) for
nicotine metabolism analysis. Afterwards, you will be asked to familiarize yourself with
the CReSS Pocket (see Item 5) by taking a few puffs of an electronic cigarette (see Item
6). Following this, you will be asked to smoke a cigarette (of your regular brand) with
the CReSS Pocket, at a minimum of 10 metres from any building entrance of the Labatt
Health Sciences Building. It is within your rights to refuse a cigarette at any point during
this research study and we will honour your rights. At the end of your first laboratory
session, we will schedule your second laboratory session within seven days of your first
laboratory session.
B) Abstain from smoking
You will be asked to abstain from smoking for at least 18 hours prior to your second
laboratory visit (see Item 7). We will confirm that you have not smoked in the last 18
hours by asking you to complete a second carbon monoxide test (see Item 3).
C) Second laboratory session
During your second laboratory session, smoking abstinence will first be confirmed by
breath carbon monoxide levels (see Item 3), and then you will be asked to passively sit on
a chair for 10 minutes. Approximately 5 minutes after you will smoke a cigarette using
the CReSS Pocket (see Item 5) and complete a questionnaire package (see Item 1). You
will then sit passively for approximately 30 minutes and then once again smoke a
cigarette using the CReSS Pocket (see Item 5) and complete a questionnaire packaged
(see Item 1). You will be asked to smoke outside the Labatt Health Sciences building, at
a minimum of 10 meters away from any building entrance. It is within your rights to
refuse a cigarette at any point during this research study and we will honour your rights.
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Experimental description (items 1-10)
Item 1: Questionnaire package
Time Involvement: 30 minutes
The questionnaire package will include: a demographic questionnaire, dependence on
nicotine questionnaire, physical activity questionnaire, smoking withdrawal
questionnaire, smoking motives questionnaire, stage of change questionnaire, and
questions about your cravings and comfort using the CReSS device.
Item 2: Measuring Resting Heart Rate
Time Involvement: 5 minutes
Heart rate will be measured by a Polar heart rate transmitter, which consists of a watch
and a strap held in place under your bust line by an elastic strap.
Item 3: Carbon monoxide assessments
Time Involvement: 15 seconds each
We will measure your smoking status twice by using a breath carbon monoxide analyzer:
once at each laboratory session. We will ask you to breathe into a machine called the
Bedfont Smokerlyzer. This machine measures the amount of carbon monoxide (CO) as
you breathe out. It does not cause any harm or discomfort to you. This Smokerlyzer
measures how much you have smoked in the past several hours. The second test (just
prior to treatment at the second laboratory session) will be done to verify that you have
abstained from smoking for at least 18 hours.
Item 4: Provide saliva sample on cotton swab
Time Involvement: 2 minutes
From this saliva sample we will measure the 3-hyrdroxycotinine and cotinine within your
body to determine a 3-hyrdroxycotinine/cotinine ratio. This ratio tells us about the rate at
which your body metabolizes (breaks down) nicotine.
Item 5: CReSS Pocket Device
Time Involvement: 15 minutes
We will measure your smoking topography using the CReSS Pocket. This hand-held,
computer-based machine measures how you smoke a cigarette (puff count, puff volume,
puff duration, inter-puff interval and time to first puff) by placing your cigarette in the
device and breathing through the sterilized orifice of the device. The CReSS Pocket does
not cause any harm or discomfort to you.
Item 6: Electronic cigarette
Time Involvement: 10 minutes
Electronic cigarettes, also known as e-cigarettes, are electrical devices that attempt to
simulate the act of tobacco smoking. This e-cigarette may mimic an actual cigarette
except it does not contain nicotine (0mmg of nicotine). When a smoker draws air through
the e-cigarette, an airflow sensor activates the battery that turns the tip of the cigarette red
to simulate smoking and heats the atomizer to vaporize the propylene glycol into a mist.
The vapour is odorless and vanishes quickly. Propylene glycol is an FDA-approved
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compound that is used in many food products, cosmetics, and toothpaste. Upon
inhalation, the aerosol vapor evaporates and vanishes.
Item 7: Abstain from smoking for 18-24 hours
We ask that prior to your second laboratory session you abstain from smoking for at least
18 hours (18-24hours).
Risks
While in the study, you may experience side effects. Known side effects are listed below,
but other effects may occur that we cannot predict. If you are or become pregnant you
must notify the investigator as smoking involves risks to the foetus.
Temporary Smoking Abstinence: You may experience withdrawal symptoms during the
time you are abstaining from cigarettes. Such symptoms may include feeling edgy and
nervous, dizzy, sweaty, having trouble concentrating, headaches, insomnia, increased
appetite and weight gain, muscular pain, constipation, fatigue, or having an upset
stomach. All of these symptoms are common for those who quit smoking so you should
not be alarmed, as these symptoms will go away within a few days. Moderate intensity
exercise has been shown to reduce smoking withdrawal symptoms, so it could be that
those in the moderate intensity exercise treatment condition experience relief from some
of these symptoms. Another common side effect of quitting smoking is that your
“smoker’s cough” gets worse for the first few days after you quit. This is your body’s
way of attempting to rid the lungs of excess toxins. Your smoker’s cough will improve to
a great extent after you have become smoke-free for a number of days.
Benefits
Involvement in this study could assist you in becoming smoke free. You may not get a
personal benefit from participating in this study but your participation may help us get
knowledge to shape the development of future exercise and smoking cessation programs.
Participation
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any time with no effect on your academic or
employment status. If you decide to take part you will be given this Letter of Information
to keep and be asked to sign the consent form. If you withdraw from the study, you
maintain the right to request that any data collected from you not be used in the study. If
you make such a request, all of the data collected from you will be destroyed. Please
contact the study coordinator, Terri Schneider, if you wish to withdraw from the study. If
you are participating in another study at this time, please inform the study researchers
right away to determine if it is appropriate for you to participate in this study.
Biological Specimens
The sample we are asking of you during the course of this study is saliva. This saliva
sample will be used for the current study only. The saliva sample will be frozen in our
laboratory freezer, then shipped and analyzed at the University of Toronto in Canada for
an indication of how quickly you metabolize (break down) nicotine in your body (3-
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hydroxycotinine: cotinine ratio). Bar codes will be used to label your saliva samples, so
the laboratory technicians analyzing your saliva will have no information as to who
provided the saliva sample. The samples will be stored for a minimum of 3 years. Usage
and potential research value will be reviewed annually thereafter. It is typical to keep the
samples collected from a research study for 6 years after the study has been conducted.
Once the research value is deemed lower than sufficient to justify storage costs, the
samples will be destroyed by standard disposal of biohazardous waste laboratory policies
and procedures. If we would like to use your saliva for a different study or for a different
purpose in this study, we will send you a new letter of information and ask your
permission.
Any specimen(s) obtained for the purposes of this study will become the property of the
study researchers and once you have provided the specimens you will not have access to
them. The specimen(s) will be discarded or destroyed once they have been used for the
purposes described in the protocol. The specimen(s) will be used for research and such
use may result in inventions or discoveries that could become the basis for new products
or diagnostic or therapeutic agents. In some instances, these inventions and discoveries
may be of potential commercial value and may be patented and licensed by the
researcher. It is not the purpose of this study to use specimens for any inventions or
patents, so it is very unlikely that this will occur as an outcome of a sample you provide
us with. You will not receive any money or other benefits derived from any commercial
or other products that may be developed from use of the specimens.
New Findings
If, during the course of this study, new information becomes available that may relate to
your willingness to continue to participate, this information will be provided to you by
the investigator.
Confidentiality
We will be collecting information from 100 participants for this study. All the
information you provide to the researcher will be kept in the strictest confidence. You
will be assigned an identification number and all data collected from you will be recorded
and stored under this number only. All data will be stored in coded form on computers
accessible only to research staff in a secure office. You will not be identified in any
documents relating to the research. No information obtained during the study will be
discussed with anyone outside of the research team. If the results of the study are
published, your name will not be used.
Representatives of the University of Western Ontario Health Sciences Research Ethics
Board and regulatory bodies (Health Canada) may contact you or require access to your
study-related records to monitor the conduct of the research. If we find information we
are required by law to disclose, we cannot guarantee confidentiality. We will strive to
ensure the confidentiality of your research- related records. Absolute confidentiality
cannot be guaranteed as we may have to disclose certain information under certain laws.
Compensation
Free parking will be provided for your visits to the laboratory. If public transportation is
required for participation in this study you will be reimbursed to a maximum of $10.00.
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If you have private medical or life insurance, you should check with your insurance
company before you agree to take part in the study to confirm your participation in this
study will not affect your insurance coverage and/or access to benefits.
This study is covered by an insurance policy and if during the course of the study any
injury should occur to you, not due to your fault or negligence, all medical expenses
necessary to treat such injury will be paid provided: a) you comply at all times with the
study researcher’s instructions b) you promptly report any such injury to the study
researchers conducting the study, and c) the expenses are not otherwise covered by your
provincial health care. Financial compensation for such things as lost wages, disability or
discomfort due to this type of injury is not routinely available. You do not waive any
legal rights by signing the consent form.
Alternative treatments
If you decide not to participate or if you withdraw from the study before it is completed,
the alternative course of treatment could be to see your family physician for advice on
how to quit smoking. Another alternative to the procedures described above is not to
participate in the study and continue on just as you do now.
Optional Follow-Up Telephone Interviews
At the completion of the study, you will be given the option of participating in the
follow-up phase of this study, consisting of a yearly update of your health and/or the reuse of your smoking behavior information. This will consist of a short telephone
interview (less than 15 minutes) conducted once a year, for twenty years, where we will
ask you if you have had any major health complications in the past year, such as heart
disease or cancer. This research has the same purpose as the original study with a focus
on comparing these issues between males and females and identifying potential
contributors to future health status. If you choose to provide consent, your smoking
topography, nicotine metabolism, and questionnaire data will be used in future smokingrelated research. Your confidentiality will be protected as outlined above (refer to page
5).
If you would like to have your name and contact information kept on file, we can ask you
about the possibility of participating in future studies. If you agree to participate in the
study follow-up and/or be contacted for participation in other studies, you may refuse to
answer any questions or withdraw your consent at any time by informing a member of
the research team. Your name and contact information will not be shared with anyone
outside of the research team. The potential risks and discomfort, benefits and
confidentiality and privacy issues are identical to those outlined in the confidentiality
section of this Letter of Information. You will not be compensated financially for
participation in the follow-up phase of this study. If you have any questions or concerns
about this research, you should contact study investigators.
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Contact person(s)
If you have any questions about your rights as a research participant or the conduct of the
study you may contact Dr. David Hill, Scientific Director, Lawson Health Research
Institute. If you have any questions about the study, please contact the study coordinator,
Terri Schneider.
This letter is for you to keep. You will be given a copy of this letter of information and
consent form once it has been signed. If you have any concerns, please feel free to
contact one of the researchers below. You may request the general findings of this
research study from the researchers after the study is complete. You do not waive any
legal rights by singing the consent form.
Terri Schneider
Graduate Student
School of Kinesiology,
Western University

Stefanie De Jesus
Graduate Student
School of Kinesiology,
Western University

Dr. Harry Prapavessis
Professor
School of Kinesiology,
Western University
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LETTER OF INFORMATION
Study Title: Does an acute bout of exercise affect smoking satisfaction?
Principal Study Investigator:
Harry Prapavessis, Ph.D. (School of Kinesiology, Western University)
Co-Investigators:
Terri Schneider, B.A. (School of Kinesiology, Western University)
Stefanie De Jesus, Ph.D. (cond.), M.A., B.Sc. (School of Kinesiology, Western
University)
You are being invited to participate in a research study looking at the effects of a short
period of exercise on smoking behaviour. This is a randomized control trial (a type of
research study), which includes eligible volunteers who choose to take part. Please take
your time to make a decision, and discuss this proposal with your personal doctor, family
members and friends as you feel inclined. The purpose of this letter is to provide you
with the information you require to make an informed decision on participating in this
research. This letter contains information to help you decide whether or not to participate
in this research study. It is important for you to know why the study is being conducted
and what it will involve. Please take the time to read this carefully and feel free to ask
questions if anything is unclear or there are words or phrases you do not understand. We
are asking you to take part because you are an adult between 18 and 64 years of age who
smokes.
Purpose of the Study
Exercise has been shown to help with traditional cessation strategies. A single bout of
exercise, low to moderate in intensity, can help regulate cravings, withdrawal symptoms
and smoking topography. Smoking topography refers to the measurement of smoking
behaviour, which includes puff volume, maximum puff velocity, inter-puff interval, puff
duration, number of puffs per cigarette, and the time to smoke a single cigarette.
The primary objective of this study is to examine the effects of an acute bout of moderate
intensity exercise on smoking satisfaction and smoking behaviour (smoking topography)
following a period of smoking abstinence. The second purpose of this study is to assess
the influence of nicotine metabolism rate (how quickly your body breaks down nicotine)
on smoking satisfaction and topography.
Participants
One hundred participants will be asked to take part in this research. To be eligible to
participate, you must meet the following criteria: 18 to 64 years of age, smoke 10 or
more cigarettes per day for more than 2 years, have not engaged in a serious quit attempt
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in the last six months, must not be suffering from an illness (e.g. cold) that would affect
your typical smoking behavior, do not have a medical condition that prevents you from
exercising, not be pregnant or intending on becoming pregnant. You must also be able to
read and write in English and have a telephone or e-mail account that the investigators
can contact you at.
Research Procedure
If you choose to take part in this study, you will be asked to complete three study
components: A) the first laboratory session, B) abstain from smoking, C) the second
laboratory session.
The laboratory sessions will be held at the Exercise and Health Psychology Laboratory
(EHPL) at The University of Western Ontario (UWO). The EHPL is located in Room
408 of the Labatt Health Sciences Building. Prior to the first meeting you will be asked
to complete the Physical Activity Readiness Questionnaire (PAR-Q). The pre-screening
period, including the completion of the PAR-Q will take approximately 20 minutes to
complete. Each laboratory meeting will take approximately 75 minutes.
A) First laboratory session
During your first laboratory session, complete a questionnaire package (see Item 1) and
the following information will be collected: resting heart rate (see Item 2), weight, height,
breath carbon monoxide levels (see Item 3) and saliva samples (see Item 4) for nicotine
metabolism analysis. Afterwards, you will be asked to familiarize yourself with the
CReSS Pocket (see Item 5) by taking a few puffs of an electronic cigarette (see Item 6).
Following this, you will be asked to smoke a cigarette (of your regular brand) with the
CReSS Pocket, at a minimum of 10 metres from any building entrance of the Labatt
Health Sciences Building. It is within your rights to refuse a cigarette at any point during
this research study and we will honour your rights. At the end of your first laboratory
session, we will schedule your second laboratory session within seven days of your first
laboratory session.
B) Abstain from smoking
You will be asked to abstain from smoking for at least 18 hours prior to your second
laboratory visit (see Item 7). We will confirm that you have not smoked in the last 18
hours by getting you to complete a second carbon monoxide test (see Item 3).
C) Second laboratory session
During your second laboratory session, smoking abstinence will first be confirmed by
breath carbon monoxide levels (see Item 3), and then you will be asked to exercise at a
moderate intensity on a treadmill for 10 minutes. Approximately 5 minutes after exercise
you will smoke a cigarette using the CReSS Pocket (see Item 5) and complete a
questionnaire package (see Item 1). You will then sit passively for approximately 30
minutes and then once again smoke a cigarette using the CReSS Pocket (see Item 5) and
complete a questionnaire package (see Item 1). You will be asked to smoke outside the
Labatt Health Sciences Building, at a minimum of 10 meters away from any building
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entrance. It is within your rights to refuse a cigarette at any point during this research
study and we will honour your rights.
Experimental description (items 1-10)
Item 1: Questionnaire package
Time Involvement: 30 minutes
The questionnaire package will include: a demographic questionnaire, dependence on
nicotine questionnaire, physical activity questionnaire, smoking withdrawal
questionnaire, smoking motives questionnaire, stage of change questionnaire, and
questions about your cravings and comfort using the CReSS device.
Item 2: Measuring Resting Heart Rate
Time Involvement: 5 minutes
Heart rate will be measured by a Polar heart rate transmitter, which consists of a watch
and a strap held in place under your bust line by an elastic strap.
Item 3: Carbon monoxide assessments
Time Involvement: 15 seconds each
We will measure your smoking status twice by using a breath carbon monoxide analyzer:
once at each laboratory session. We will ask you to breathe into a machine called the
Bedfont Smokerlyzer. This machine measures the amount of carbon monoxide (CO) as
you breathe out. It does not cause any harm or discomfort to you. This Smokerlyzer
measures how much you have smoked in the past several hours. The second test (just
prior to treatment at the second laboratory session) will be done to verify that you have
abstained from smoking for at least 18 hours.
Item 4: Provide saliva sample on cotton swab
Time Involvement: 2 minutes
From this saliva sample we will measure the 3-hyrdroxycotinine and cotinine within your
body to determine a 3-hyrdroxycotinine/cotinine ratio. This ratio tells us about the rate at
which your body metabolizes (breaks down) nicotine.
Item 5: CReSS Pocket Device
Time Involvement: 15 minutes
We will measure your smoking topography using the CReSS Pocket. This hand-held,
computer-based machine measures how you smoke a cigarette (puff count, puff volume,
puff duration, inter-puff interval and time to first puff) by placing your cigarette in the
device and breathing through the sterilized orifice of the device. The CReSS Pocket does
not cause any harm or discomfort to you.
Item 6: Electronic Cigarette
Time Involvement: 10 minutes
Electronic cigarettes, also known as e-cigarettes, are electrical devices that attempt to
simulate the act of tobacco smoking. This e-cigarette may mimic an actual cigarette
except it does not contain nicotine (0mmg of nicotine). When a smoker draws air through
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the e-cigarette, an airflow sensor activates the battery that turns the tip of the cigarette red
to simulate smoking and heats the atomizer to vaporize the propylene glycol into a mist.
The vapour is odorless and vanishes quickly. Propylene glycol is an FDA-approved
compound that is used in many food products, cosmetics, and toothpaste. Upon
inhalation, the aerosol vapor evaporates and vanishes.
Item 7: Abstain from smoking for 18-24 hours
We ask that prior to your second laboratory session you abstain from smoking for at least
18 hours (18-24hours).
Risks
While in the study, you may experience side effects. Known side effects are listed below,
but other effects may occur that we cannot predict. If you are or become pregnant you
must notify the investigator as smoking involves risks to the foetus.
Exercise: There are some inherent risks of injury associated with exercise participation,
particularly among people who are not used to exercising. You may, for example, feel
mild muscle “tightness” or soreness that lasts for a couple of days. The possible benefits
associated with exercise may outweigh the potential minor discomfort of beginning a
supervised, laboratory-based exercise program. To minimize the physical risks of
exercise, proper warm-up/cool-down and stretching protocols will be performed by a
trained exercise counsellor. Additionally, the exercise program delivered will be tailored
to your individual fitness level, and modified according to your comfort level.
Furthermore, you will only be allowed to participate in this exercise program if you
complete the PAR-Q (Physical Activity Readiness Questionnaire) forms to ensure that it
is safe for you to begin an exercise program. The exercise facilitator will be both CPR
and First Aid trained, and experienced in working with previously inactive populations.
If any physical or mental risks arise during treatment, The Student Emergency Response
Team (SERT) will be available to provide immediate assistance. SERT will assist the
exercise supervisor until the 911 emergency services arrive. Should you have a minor
injury while exercising you will receive medical treatment onsite as required. A first aid
kit and ice packs will be available for minor injuries.
Temporary Smoking Abstinence: You may experience withdrawal symptoms during the
time you are abstaining from cigarettes. Such symptoms may include feeling edgy and
nervous, dizzy, sweaty, having trouble concentrating, headaches, insomnia, increased
appetite and weight gain, muscular pain, constipation, fatigue, or having an upset
stomach. All of these symptoms are common for those who quit smoking so you should
not be alarmed, as these symptoms will go away within a few days. Moderate intensity
exercise has been shown to reduce smoking withdrawal symptoms, so it could be that
those in the moderate intensity exercise treatment condition experience relief from some
of these symptoms. Another common side effect of quitting smoking is that your
“smoker’s cough” gets worse for the first few days after you quit. This is your body’s
way of attempting to rid the lungs of excess toxins. Your smoker’s cough will improve to
a great extent after you have become smoke-free for a number of days.
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Benefits
Involvement in this study could assist you in becoming smoke free. You may not get a
personal benefit from participating in this study but your participation may help us get
knowledge to shape the development of future exercise and smoking cessation programs.
Participation
Participation in this study is voluntary. You may refuse to participate, refuse to answer
any questions or withdraw from the study at any time with no effect on your academic or
employment status. If you decide to take part you will be given this Letter of Information
to keep and be asked to sign the consent form. If you withdraw from the study, you
maintain the right to request that any data collected from you not be used in the study. If
you make such a request, all of the data collected from you will be destroyed. Please
contact the study coordinator if you wish to withdraw from the study. If you are
participating in another study at this time, please inform the study researchers right away
to determine if it is appropriate for you to participate in this study.
Biological Specimens
The sample we are asking of you during the course of this study is saliva. This saliva
sample will be used for the current study only. The saliva sample will be frozen in our
laboratory freezer, then shipped and analyzed at the University of Toronto in Canada for
an indication of how quickly you metabolize (break down) nicotine in your body (3hydroxycotinine: cotinine ratio). Bar codes will be used to label your saliva samples, so
the laboratory technicians analyzing your saliva will have no information as to who
provided the saliva sample. The samples will be stored for a minimum of 3 years. Usage
and potential research value will be reviewed annually thereafter. It is typical to keep the
samples collected from a research study for 6 years after the study has been conducted.
Once the research value is deemed lower than sufficient to justify storage costs, the
samples will be destroyed by standard disposal of biohazardous waste laboratory policies
and procedures. If we would like to use your saliva for a different study or for a different
purpose in this study, we will send you a new letter of information and ask your
permission.
Any specimen(s) obtained for the purposes of this study will become the property of the
study researchers and once you have provided the specimens you will not have access to
them. The specimen(s) will be discarded or destroyed once they have been used for the
purposes described in the protocol. The specimen(s) will be used for research and such
use may result in inventions or discoveries that could become the basis for new products
or diagnostic or therapeutic agents. In some instances, these inventions and discoveries
may be of potential commercial value and may be patented and licensed by the
researcher. It is not the purpose of this study to use specimens for any inventions or
patents, so it is very unlikely that this will occur as an outcome of a sample you provide
us with. You will not receive any money or other benefits derived from any commercial
or other products that may be developed from use of the specimens.
New Findings
If, during the course of this study, new information becomes available that may relate to
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your willingness to continue to participate, this information will be provided to you by
the investigator.
Confidentiality
We will be collecting information from 100 participants for this study. All the
information you provide to the researcher will be kept in the strictest confidence. You
will be assigned an identification number and all data collected from you will be recorded
and stored under this number only. All data will be stored in coded form on computers
accessible only to research staff in a secure office. You will not be identified in any
documents relating to the research. No information obtained during the study will be
discussed with anyone outside of the research team. If the results of the study are
published, your name will not be used.
Representatives of the University of Western Ontario Health Sciences Research Ethics
Board and regulatory bodies (Health Canada) may contact you or require access to your
study-related records to monitor the conduct of the research. If we find information we
are required by law to disclose, we cannot guarantee confidentiality. We will strive to
ensure the confidentiality of your research-related records. Absolute confidentiality
cannot be guaranteed as we may have to disclose certain information under certain laws.
Compensation
Free parking will be provided for your visits to the laboratory. If public transportation is
required for participation in this study you will be reimbursed to a maximum of $10.00.
If you have private medical or life insurance, you should check with your insurance
company before you agree to take part in the study to confirm your participation in this
study will not affect your insurance coverage and/or access to benefits.
This study is covered by an insurance policy and if during the course of the study any
injury should occur to you, not due to your fault or negligence, all medical expenses
necessary to treat such injury will be paid provided: a) you comply at all times with the
study researcher’s instructions b) you promptly report any such injury to the study
researchers conducting the study, and c) the expenses are not otherwise covered by your
provincial health care. Financial compensation for such things as lost wages, disability or
discomfort due to this type of injury is not routinely available. You do not waive any
legal rights by signing the consent form.
Alternative treatments
If you decide not to participate or if you withdraw from the study before it is completed,
the alternative course of treatment could be to see your family physician for advice on
how to quit smoking. Another alternative to the procedures described above is not to
participate in the study and continue on just as you do now.
Optional Follow-Up Telephone Interviews
At the completion of the study, you will be given the option of participating in the
follow-up phase of this study, consisting of a yearly update of your health and/or the re-
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use of your smoking behaviour information. This will consist of a short telephone
interview (less than 15 minutes) conducted once a year, for twenty years, where we will
ask you if you have had any major health complications in the past year, such as heart
disease or cancer. This research has the same purpose as the original study with a focus
on comparing these issues between males and females and identifying potential
contributors to future health status. If you choose to provide consent, your smoking
topography, nicotine metabolism, and questionnaire data will be used in future smokingrelated research. Your confidentiality will be protected as outlined above (refer to page
5).

If you would like to have your name and contact information kept on file, we can ask you
about the possibility of participating in future studies. If you agree to participate in the
study follow-up and/or be contacted for participation in other studies, you may refuse to
answer any questions or withdraw your consent at any time by informing a member of
the research team. Your name and contact information will not be shared with anyone
outside our Research Team. The potential risks and discomfort, benefits and
confidentiality and privacy issues are identical to those outlined in the confidentiality
section of this letter of information. You will not be compensated financially for
participation in the follow-up phase of this study. If you have any questions or concerns
about this research, you should contact study investigators.
Contact person(s)
If you have any questions about your rights as a research participant or the conduct of the
study you may contact Dr. David Hill, Scientific Director, Lawson Health Research
Institute. If you have any questions about the study, please contact the study coordinator,
Terri Schneider.
This letter is for you to keep. You will be given a copy of this letter of information and
consent form once it has been signed. If you have any concerns, please feel free to
contact one of the researchers below. You may request the general findings of this
research study from the researchers after the study is complete. You do no waive any
legal rights by signing the consent form.

Terri Schneider
Graduate Student
School of Kinesiology,
Western University

Stefanie De Jesus
Graduate Student
School of Kinesiology,
Western University

Dr. Harry Prapavessis
Professor
School of Kinesiology,
Western University
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INFORMED CONSENT
Study Title: Does an acute bout of exercise effect smoking satisfaction?
I have read the Letter of Information, have had the nature of the study explained to me
and I agree to participate. All questions have been answered to my satisfaction.

Please send me the overall conclusions from this trial:

Yes □ No □

I consent for my study related data to be used in future research studies:

Yes □ No □

I would like to be contacted for other research studies:

Yes □ No □

I would like to participated in the follow-up phase of the study:

Yes □ No □

Consenting Signature:
Participant: ________________________________________________________
Please Print Name

Participant: ________________________________________________________
Please Sign Name
Date: ___________________

Researcher Signature:
Person obtaining informed consent:

_______________________________________
Please Print Name

Person obtaining informed consent:

Date: ___________________

_______________________________________
Please Sign Name
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DEBRIEFING LETTER OF INFORMATION
Study Title: Does an acute bout of exercise affect smoking satisfaction?
Principal Study Investigator:
Harry Prapavessis, Ph.D. (School of Kinesiology, Western University)
Co-Investigators:
Terri Schneider, B.A. (School of Kinesiology, Western University)
Stefanie De Jesus, Ph.D. (cond.), M.A., B.Sc. (School of Kinesiology, Western
University)
The purpose of this study was to examine the effects of an acute bout of moderate
intensity exercise on smoking satisfaction and smoking behaviour (smoking topography)
following a period of smoking abstinence. The second purpose of this study was to
assess the influence of nicotine metabolism rate (how quickly your body breaks down
nicotine) on smoking topography. Previous research has shown that a single bout of
exercise, low to moderate in intensity, can help regulate cravings, withdrawal symptoms
and smoking topography. Smoking topography refers to the measurement of smoking
behaviour, which includes puff volume, maximum puff velocity, inter-puff interval, puff
duration, number of puffs per cigarette, and the time to smoke a single cigarette.
In this study, participants were asked to become familiar with the CReSS device using an
electronic cigarette (0mmg of nicotine), complete a questionnaire package, provide
carbon monoxide levels, saliva samples, and smoking topography information using the
CReSS Pocket. The purpose of these measures was to examine your smoking behaviour,
confirm smoking abstinence and assess the influence of nicotine metabolism rate (how
quickly your body breaks down nicotine) on smoking topography.
There were two groups in this study assigned at random (like the flip of a coin): 1) a
Moderate Exercise Group and 2) a Passive Sitting Group. Participants in the Moderate
Exercise Group exercised at a moderate intensity for 10 minutes on a treadmill at the
Exercise and Health Psychology Laboratory (EHPL). Participants in the Passive Sitting
Group sat passively for 10 minutes on a chair in the EHPL. You were not informed of
the two groups at the beginning of the study in order to eliminate potential bias and
contamination. This simply means that having knowledge of the two conditions
(Moderate Exercise Group and Passive Sitting Group) may have influenced your
responses and smoking topography.
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Continued participation in this study was voluntary. You may refuse to participate,
refuse to have your information used in the study, and refuse to answer any questions or
withdraw from the study at any time with no effect on your academic or employment
status.
If you have any additional questions, comments or concerns about the study, please do
not hesitate to contact Terri Schneider, Stefanie De Jesus, or Harry Prapavessis.
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I have read the Debriefing Letter of Information, have had the nature of the study
explained to me and I agree for my data to be used in the study analysis. All questions
have been answered to my satisfaction.
Consenting Signature:
Participant: ________________________________________________________
Please Print Name

Participant: ________________________________________________________
Please Sign Name
Date: ___________________

Researcher Signature:
Person obtaining informed consent:

_______________________________________
Please Print Name

Person obtaining informed consent:

_______________________________________
Please Sign Name

Date: ___________________
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DEMOGRAPHIC QUESTIONNAIRE
First Name: _________________ Last Name: ______________________

ID: ______

Address:___________________________________________________________
STREET ADDRESS, CITY, POSTAL CODE

Home Phone: ________- _________-_________
Email Address:___________________________@___________________
Date of Birth: ________/________/___________

Age: ______

Gender:

_______

Height: __________

Weight: ___________

BMI: ____________

SMOKING STATUS AND HISTORY
Please indicate the length of time you have smoked: _______
On average, how many cigarettes do you smoke per day? : _________
Do you currently smoke any other substance besides cigarettes?

 Yes

 No

If yes, please specify (e.g. marijuana, cigar, pipe, cigarello, waterpipe tobacco/hookah):
________________________________________________________________________
Have you ever smoked any other substance besides cigarettes?

 Yes

 No

If yes, please specify (e.g. marijuana, cigar, pipe, cigarello, waterpipe tobacco/hookah):
_____________________________________________________________________
Does anyone in your household currently smoke?

 Yes

 No

Do you drink Alcohol?

 Yes

 No

If yes, number of drinks per week? _____________
What is the approximate date and time of the last cigarette you have smoked?
Date: ______________

Time: ________________
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At what age did you smoke your first cigarette? ________
What brand of cigarette do you smoke most of the time? __________________________

Do you smoke

 Filter cigarettes

Do you smoke

 regular

 Non-filter cigarettes

 king size





Do you smoke your cigarette about

 extra large cigarettes

1/4 of the length
1/2 of the length
3/4 of the length
all the way to the end (the filter)

Do you simply puff your cigarette without inhaling the smoke?

Do you inhale the smoke






seldom
occasional
often
always

How long have you been smoking regularly? ________

 Yes

 No
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
We are interested in finding out about the kinds of physical activities that people
do as part of their everyday lives. The questions will ask you about the time you
spent being physically active in the last 7 days. Please answer each question
even if you do not consider yourself to be an active person. Please think about
the activities you do at work, as part of your house and yard work, to get from
place to place, and in your spare time for recreation, exercise or sport.
Think about all the vigorous activities that you did in the last 7 days. Vigorous
physical activities refer to activities that take hard physical effort and make you
breathe much harder than normal. Think only about those physical activities that
you did for at least 10 minutes at a time.
1.

During the last 7 days, on how many days did you do vigorous physical
activities like heavy lifting, digging, aerobics, or fast bicycling?
_____ days per week

No vigorous physical activities
2.

Skip to question 3

How much time did you usually spend doing vigorous physical activities
on one of those days?
_____ hours per day
_____ minutes per day

Don’t know/Not sure
Think about all the moderate activities that you did in the last 7 days. Moderate
activities refer to activities that take moderate physical effort and make you
breathe somewhat harder than normal. Think only about those physical activities
that you did for at least 10 minutes at a time.
3.

During the last 7 days, on how many days did you do moderate physical
activities like carrying light loads, bicycling at a regular pace, or doubles
tennis? Do not include walking.

_____ days per week
No moderate physical activities

Skip to question 5
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4.

How much time did you usually spend doing moderate physical activities
on one of those days?
_____ hours per day
_____ minutes per day
Don’t know/Not sure

Think about the time you spent walking in the last 7 days. This includes at work
and at home, walking to travel from place to place, and any other walking that
you might do solely for recreation, sport, exercise, or leisure.
5.

During the last 7 days, on how many days did you walk for at least 10 minutes
at a time?
_____ days per week

No walking

6.

Skip to question 7

How much time did you usually spend walking on one of those days?
_____ hours per day
_____ minutes per day
Don’t know/Not sure

The last question is about the time you spent sitting on weekdays during the last
7 days. Include time spent at work, at home, while doing course work and during
leisure time. This may include time spent sitting at a desk, visiting friends,
reading, or sitting or lying down to watch television.
7. During the last 7 days, how much time did you spend sitting on a week
day?
_____ hours per day
_____ minutes per day
Don’t know/Not sure
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ID: _______
FAGERSTROM TEST FOR NICOTINE DEPENDENCE
1. How soon after you wake up do you smoke your first cigarette?
a) After 60 minutes
b) 31-60 minutes
c) 6-30 minutes
d) Within 5 minutes
2. Do you find it difficult to refrain from smoking in places where it is forbidden?
a) No
b) Yes
3. Which cigarette would you most hate to give up?
a) The first in the morning
b) Any other
4. How many cigarettes per day do you smoke?
a) 10 or less
b) 11-20
c) 21-30
d) 30 or more
5. Do you smoke more frequently during the first hours after awakening than
during the rest of the day?
a) No
b) Yes
6. Do you smoke even if you are so ill that you are in bed most of the day?
a) No
b) Yes
\
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ID: _______

Desire to Smoke

Using a seven-point scale, please respond to the following
statement: ‘I have a desire to smoke’

1
Strongly
agree

2

3

4
Neither agree nor
disagree

5

6

7
Strongly
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PHYSIOLOGICAL DATA
Carbon Monoxide
Visit 1 Micro Smokerlyzer: ______

Visit 2 Micro Smokerlyzer: ______
Visit 2 Number of hours abstained: ______

Exercise Prescription
HRrest: _____
Age: ______
HRmax: 220bpm - _____ (age) = ______
HRR: ______ (HRmax) - ______ (HRrest) = _______

45% of HRR is calculated as follows:

68% of HRR is calculated as follows:

[(HRmax - HRrest) x %] + HRrest

[(HRmax - HRrest) x %] + HRrest

[(___) – (____) x 0.45] + ____ = _____

[(____) – (____) x 0.68] + _____ = _______

Exercise session:
Warm up

Length: __________

Total duration: ___________

Speed: __________

Incline: _________ HR: _____

Nicotine Metabolism
Saliva sample taken:

 Yes

 No

CYP2A6 genotype (polymorphism): _______
CYP2A6 phenotype:

 High metabolism
 Intermediate metabolism
 Slow metabolism
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ACCEPTABILITY QUESTIONNAIRE

ID: _______

Please put a mark on the line that best describes the question being asked in regards to
your experience with the Portable Smoking Topography Measurement Device (CReSS
Pocket) that used during your laboratory visits compared to smoking a cigarette without
the CReSS Pocket.
The CReSS Pocket altered how much I puffed (i.e. puff volume)
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

70

80

90
100
STRONGLY
AGREE

70

80

90
100
STRONGLY
AGREE

70

80

90
100
STRONGLY
AGREE

80

90
100
STRONGLY
AGREE

The CReSS Pocket altered how fast I puffed (i.e. puff velocity)
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

The CReSS Pocket altered the time between my puffs
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

The CReSS Pocket altered how long I puffed (i.e. puff duration)
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

70

The CReSS Pocket altered the number of puffs I took per cigarette
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

70

80

90
100
STRONGLY
AGREE
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The CReSS Pocket altered the time to smoke my single cigarette
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

70

80

90
100
STRONGLY
AGREE

70

80

90
100
STRONGLY
AGREE

70

80

90
100
STRONGLY
AGREE

70

80

90
100
STRONGLY
AGREE

70

80

90
100
STRONGLY
AGREE

The CReSS Pocket made smoking less likely
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

The CReSS Pocket reduced smoking enjoyment
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

The CReSS Pocket affected the taste of the cigarettes
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

The CReSS Pocket made smoking more difficult
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

The CReSS Pocket increased my awareness of how much was smoked
0
10
STRONGLY
DISAGREE

20

30

40

50
60
NEUTRAL

70

80

90
100
STRONGLY
AGREE
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